fibrinogen has been researched along with Disease Exacerbation in 216 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.46) | 18.7374 |
| 1990's | 20 (9.26) | 18.2507 |
| 2000's | 63 (29.17) | 29.6817 |
| 2010's | 104 (48.15) | 24.3611 |
| 2020's | 28 (12.96) | 2.80 |
| Authors | Studies |
|---|---|
| An, H; Chen, C; Huang, C; Jin, S; Li, M; Li, S; Li, T; Li, X; Xu, Z; Ying, B; Zhang, J; Zhou, T | 1 |
| Campos-Caro, A; Córdoba-Doña, JA; García-Núñez, A; Hidalgo-Molina, A; Jiménez-Gómez, G; León-Jiménez, A | 1 |
| Andresen, TL; Aznar, S; Bech, S; Blaabjerg, M; Bode, M; Brudek, T; Danielsen, EH; DellaValle, B; Folke, J; Hejl, AM; Hempel, C; Løkkegaard, A; Møller, M; Olsen, JV; Pakkenberg, B; Rungby, J; Rydbirk, R; Salvesen, L; Starhof, CC; Winge, K; Østergaard, O | 1 |
| Dong, L; Jiang, Z; Qin, A; Qin, W; Tan, J; Tang, Y; Wang, S; Yang, D | 1 |
| Altintop, SE; Cihangiroglu, M; Gozukara, B; Gozukara, M; Milletli-Sezgin, F; Onarer, P; Unalan-Altintop, T; Zengin, E | 1 |
| Liu, LL; Liu, N; Yang, WG; Yao, L; Zhang, JX; Zheng, JN; Zhu, R | 1 |
| Man, L; Zhang, Y | 1 |
| Abdullah, M; Gathmyr, D; Harahap, AT; Harimurti, K; Irawan, C; Lubis, AM; Nainggolan, L; Shatri, H; Susilo, A | 1 |
| Cao, C; Jiang, X; Liu, S; Lu, S; Niu, X; Qiao, Z; Shang, Z; Xiao, H; Zhang, K | 1 |
| Cui, S; Ding, D; Li, X; Liu, J; Shu, K; Yu, Q; Zhou, J; Zhou, R | 1 |
| Cardinale, M; Cungi, PJ; D'Aranda, E; Dagain, A; Esnault, P; Goutorbe, P; Joubert, C; Mathais, Q; Meaudre, E; Montcriol, A | 1 |
| Dong, Q; Dong, QT; Gao, Y; Guo, YL; Li, JJ; Liu, SL; Shi, HW; Wu, NQ | 1 |
| Du, WT; Li, X; Wu, ZX; Xu, DX; Yu, GF | 1 |
| Gibbons, LP; Holden, NS; Jenkins, AR; Jones, AW | 1 |
| Fu, X; Li, H; Liu, W; Long, H; Nie, L; Ren, H; Wang, Q; Wu, Q; Xiang, X; Zhang, X | 1 |
| Azar, R; Bacri, JL; Bobrie, G; Boffa, JJ; Clabault, K; Colombat, M; Ducloux, D; Dürrbach, A; Duvic, C; El Karoui, K; Ferlicot, S; François, H; Garrigue, V; Guerrot, D; Hoffmann, M; Lionet, A; Mansour, J; Meyer, L; Mousson, C; Nochy, D; Panescu, V; Plaisier, E; Ratsimbazafy, A; Ulrich, M; Valleix, S; Vigneau, C; Vrigneaud, L | 1 |
| Badley, AD; Barnathan, ES; Gores, GJ; Halamka, J; Houghton, DE; Khan, N; Loscalzo, L; Makimura, H; Morice, WG; Murugadoss, K; O'Horo, JC; Pawlowski, C; Pruthi, RK; Puranik, A; Soundararajan, V; Venkatakrishnan, AJ; Wagner, T; Williams, AW | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Benoit, JL; Benoit, SW; Favaloro, EJ; Henry, BM; Hoehn, J; Lippi, G | 1 |
| Dounavi, ME; Low, A; Mak, E; Markus, HS; Muniz-Terrera, G; O'Brien, JT; Ritchie, CW; Ritchie, K; Stefaniak, JD; Su, L | 1 |
| Hu, JM; Jiang, CH; Li, F; Li, FP; Li, JF; Li, Y; Liang, WH; Liu, CX; Pang, LJ; Shen, XH; Xie, YF; Yuan, X; Zhang, AZ; Zhang, HJ | 1 |
| Fei, X; Huang, Q; Ma, J; Song, Y; Wo, M; Wu, H | 1 |
| Cheng, NS; Hu, HJ; Lu, J; Xiong, XZ; Ye, XW | 1 |
| Hifumi, T; Ito, T; Yamamoto, A | 1 |
| Cheng, XX; Fu, M; Liao, YC; Wang, XF | 1 |
| Agodirin, OS; Izuegbuna, OO; Olatoke, SA; Olawumi, HO | 1 |
| Criner, GJ; Dransfield, MT; Halpin, DMG; Han, MK; Lange, P; Lettis, S; Lipson, DA; Lomas, D; Mannino, D; Martin, N; Martinez, FJ; Miller, BE; Singh, D; Wise, R; Zhu, CQ | 1 |
| Alkan, M; Altunok, ES; Börü, A; Demirkol, MA; Demirok, B; Gürsoy, B; Kamat, S; Satıcı, C; Sürmeli, CD | 1 |
| Andrijevic, I; Andrijevic, L; Jokic, D; Milutinov, S; Vukoja, M | 1 |
| Chauhan, AK; Chorawala, MR; Dhanesha, N; Doddapattar, P; Kokame, K; Lentz, SR; Nayak, MK; Staber, JM | 1 |
| Jiang, Q; Liu, Z; Lu, Y; Wang, H; Yin, R; Zheng, C; Zhou, M; Zhu, P | 1 |
| Garg, VK; Goyal, MK; Lal, V; Mittal, BR; Modi, M; Mohanty, M; Prabhakar, S; Vishnu, VY | 1 |
| Bekos, C; Brodowicz, T; Grimm, C; Hefler, L; Koch, H; Petru, E; Polterauer, M; Polterauer, S; Reimer, D; Reinthaller, A | 1 |
| Baker, NL; Hunt, KJ; Jarai, G; Klein, RL; Lopes-Virella, MF; Rosen, GD; Stevens, DR; Virella, G | 1 |
| Becker, F; Blaise, S; Desmurs-Clavel, H; Jeancolas, J; Jurus, C; Laaeng Massoni, C; Laroche, JP; Maloizel-Delaunay, J; Mestre-Godin, S; Nou-Howaldt, M; Pichot, O; Sarlon-Bartoli, G; Sevestre-Pietri, MA; Soulier-Sotto, V; Thiel, H | 1 |
| Clark, RAF; Fenner, J; McClain, SA; Sasson, A; Singer, AJ; Tonnesen, MG | 1 |
| Nakagawa, K; Nakashima, Y | 1 |
| Gong, Z; Yan, C; Yang, Q | 1 |
| Guo, R; Han, Q; Li, H; Li, L; Liu, F; Wang, S; Wang, T; Wang, Y; Wu, Y; Zhang, J; Zhang, R | 1 |
| Ai, G; Huang, J; Luo, X; Ma, K; Ning, Q; Wan, X; Xi, D; Xiao, F; Yan, W; Yu, H | 1 |
| Eric Davis, R; Ezhilarasan, R; Fuller, GN; Gressot, LV; Heimberger, AB; Huang, S; Kong, LY; Latha, K; Li, S; Manyam, G; Rao, A; Rao, G; Sulman, EP; Wang, Q; Yan, J; Yang, Y | 1 |
| Katafuchi, R; Masutani, K; Mitsuiki, K; Nagae, H; Tsuruya, K | 1 |
| Hatano, T; Hiiragi, Y; Hyakusoku, H; Kuwahara, T; Matsuoka, M; Oridate, N; Sano, D; Takahashi, H | 1 |
| Agushi, E; Atkinson, R; Coope, DJ; Evans, DG; Freeman, SR; Hammerbeck-Ward, C; Hinz, R; Hulme, S; Jackson, A; King, AT; Lewis, D; Li, KL; Lloyd, SKL; Mayers, H; Mosses, D; Pathmanaban, O; Roncaroli, F; Rutherford, SA; Stapleton, E; Wadeson, A; Williams, R; Zhu, X | 1 |
| Cohen, BE; Eswarappa, M; Metzler, TJ; Neylan, TC; Whooley, MA | 1 |
| Binh, MT; Hoan, NX; Meyer, CG; Quyen, DT; Quyet, D; Son, HA; Song, LH; Toan, NL; Van Ba, N; Van Luong, H; Van Tong, H; Velavan, TP | 1 |
| Abd Alamir, M; Budoff, M; Chaus, A; Dabbous, F; Goyfman, M; Johnson, D; Liu, Y | 1 |
| Aungier, SR; Buckley, CD; Cartwright, AJ; Clanchy, FI; Culbert, E; Dyson, MR; Filer, A; Hextall, P; Karatt-Vellatt, A; Marsden, BD; Marshall, JL; McCafferty, J; Midwood, KS; Parthiban, K; Raza, K; Sahbudin, I; Schwenzer, A; Slavny, P; Williams, R | 1 |
| Davis, RE; Gabrusiewicz, K; Heimberger, AB; Huo, L; Kong, LY; Li, S; Ott, M; Rao, G; Sun, SC; Wang, J; Watowich, SS; Xia, X; Xu, J; Yan, J; Zhao, Q | 1 |
| Sun, F; Teng, J; Wang, D; Yu, PF | 1 |
| Barbosa, R; Dean, R; Dewey, EN; Fair, KA; Farrell, DH; Hilliard, C; Hinson, H; Lin, A; McCully, BH; Rick, EA; Rowell, SE; Schreiber, MA | 1 |
| Hultman, K; Norris, EH; Strickland, S | 1 |
| Ambrose, JA; Barua, RS | 1 |
| Casaburi, R; Celli, B; Crapo, J; Criner, G; Croxton, T; Gaw, A; Jones, P; Kline-Leidy, N; Lomas, DA; Merrill, D; Polkey, M; Rennard, S; Sciurba, F; Stockley, R; Tal-Singer, R; Turino, G; Vestbo, J; Walsh, J | 1 |
| Dahl, M; Ingebrigtsen, TS; Lange, P; Marott, JL; Nordestgaard, BG; Thomsen, M; Vestbo, J | 1 |
| Cao, ZG; Li, JY; Li, Y; Wang, RT | 1 |
| Chang, SJ; Ham, JH; Kim, DH; Kim, SH; Lee, JY; Lee, SS; Lim, EJ; Park, CI; Song, YK | 1 |
| Androulakis, E; Antoniades, C; Antonopoulos, A; Bouras, G; Briasoulis, A; Charakida, M; Giolis, A; Hatzis, G; Kozanitou, M; Miliou, A; Pallantza, Z; Papageorgiou, N; Stefanadis, C; Tousoulis, D | 1 |
| Ba, Y; Bai, M; Deng, T; Gao, J; Ge, S; Han, R; Huang, D; Li, H; Liu, R; Wang, H; Zhou, L | 1 |
| Donaldson, GC; Garcha, DS; George, SN; Hurst, JR; Kowlessar, BS; Mackay, AJ; Patel, AR; Singh, R; Wedzicha, JA | 1 |
| Absenger, G; Eberhard, K; Gerger, A; Leithner, A; Liegl-Atzwanger, B; Pichler, M; Ploner, F; Samonigg, H; Stojakovic, T; Stotz, M; Szkandera, J | 1 |
| Gao, CT; Hao, JH; Jin, P; Liu, Y; Luo, L; Ma, WD; Ren, H; Sun, W | 1 |
| Meade, T; Ten Cate, H | 1 |
| Ariëns, RA; Boshuizen, H; de Lange, Z; Greeff, M; Pieters, M; Schutte, AE; Schutte, R | 1 |
| Allison, MA; Callas, PW; Criqui, MH; Cushman, M | 1 |
| Ajay, AK; Bijol, V; Craciun, FL; Fabian, SL; Hoffmann, D; Humphreys, BD; Saikumar, J; Vaidya, VS | 1 |
| Cai, MY; Chen, WF; He, MJ; Hu, JW; Li, QL; Ma, LL; Qin, WZ; Xu, MD; Yao, LQ; Zhang, YQ; Zhong, YS; Zhou, PH | 1 |
| Işik, B; Karakukcu, M; Mutlu, FT; Ozdemir, MA; Patiroglu, T; Unal, E; Yilmaz, E | 1 |
| Casals, G; Crespo, G; Forns, X; Jiménez, W; Marfà, S; Morales-Ruiz, M; Navasa, M; Reichenbach, V | 1 |
| Hao, J; Liu, C; Liu, X; Man, YN; Wang, YN; Wu, XZ; Zhu, C | 1 |
| Davison, GM; Ipp, H; Nkambule, BB | 1 |
| Agewall, S; Bergström, G; Bickel, H; Bokemark, L; Bülbül, A; Catapano, AL; Chien, KL; de Groot, E; Desvarieux, M; Dörr, M; Ducimetière, P; Empana, JP; Etgen, T; Fagerberg, B; Franco, OH; Grigore, L; Hofman, A; Iglseder, B; Ikram, MA; Johnsen, SH; Kauhanen, J; Kavousi, M; Kiechl, S; Lin, HJ; Lind, L; Liu, J; Lorenz, MW; Mathiesen, EB; McLachlan, S; Norata, GD; Olsen, MH; Papagianni, A; Plichart, M; Polak, JF; Poppert, H; Price, JF; Robertson, C; Ronkainen, K; Rundek, T; Sacco, RL; Sander, D; Schmidt, C; Schminke, U; Sitzer, M; Steinmetz, H; Su, TC; Thompson, SG; Tuomainen, TP; Völzke, H; Willeit, J; Willeit, P; Xie, W; Yanez, DN; Zhao, D | 1 |
| Hamer, M; Huisman, HW; Malan, L; Malan, NT; Reimann, M; Schutte, AE; von Känel, R | 1 |
| Gerger, A; Kapp, KS; Krenn-Pilko, S; Langsenlehner, T; Langsenlehner, U; Pichler, M; Stojakovic, T; Thurner, EM | 1 |
| Ernestam, S; Forslind, K; Geborek, P; Karlsson, JA; Kastbom, A; Klareskog, L; Lundberg, K; Petersson, IF; Saevarsdottir, S; van Vollenhoven, RF | 1 |
| Koh, T; Matsumoto, H; Matsumoto, N; Ogura, H; Shimazu, T; Yamakawa, K | 1 |
| Altintas, N; Cinarka, H; Gumus, A; Hazıroglu, M; Karatas, M; Kirbas, A; Sahin, U | 1 |
| Cheng, Y; Jia, Y; Liu, H; Shao, N; Song, Q; Tan, B; Wang, J | 1 |
| Cross, RW; Fenton, KA; Geisbert, JB; Geisbert, TW; Mire, CE | 1 |
| Adams, GN; Flick, MJ; Frederick, M; Kombrinck, K; McElhinney, KE; Miller, W; Monia, BP; Palumbo, JS; Revenko, AS; Rosenfeldt, L; Waltz, D | 1 |
| Bao, W; Chen, Y; Cheng, L; Du, X; Ji, Y; Qiu, G; Sheng, L; Zhang, D; Zhou, X | 1 |
| Akhtar, M; Khan, S; Najmi, AK; Panda, BP | 1 |
| Chen, L; Chen, Y; Diao, B; Guo, S; Huang, X; Jin, M; Ning, Q; Wu, Y; Yan, W; Yang, C; Zheng, L | 1 |
| Arigami, T; Ishigami, S; Kijima, Y; Kita, Y; Kurahara, H; Matsumoto, M; Mori, S; Natsugoe, S; Okumura, H; Owaki, T; Uchikado, Y; Uenosono, Y | 1 |
| Cohen, EE; Engelmann, J; Filipits, M; Heinze, G; Kornek, G; Nkenke, E; Perisanidis, B; Perisanidis, C; Psyrri, A; Stift, A | 1 |
| Hasanspahic, S; Muslimovic, A; Rasic, S; Rebic, D; Tulumovic, D | 1 |
| Caliskan, A; Demirtas, S; Kankilic, N; Karahan, O; Mavitas, B; Tezcan, O; Yavuz, C | 1 |
| Fischer, R; Jiang, X; Kessler, BM; Lundberg, K; Midwood, KS; Mikuls, TR; Payne, JB; Quirke, AM; Sayles, HR; Schwenzer, A; Venables, PJ | 1 |
| Forssell, H; Freitag, M; Halling, A; Lindblad, U; Odeberg, H; Odeberg, J; Persson, ML; Råstam, L; Vaara, I | 1 |
| Byun, SS; Hong, SK; Kim, HH; Kwak, C; Lee, H; Lee, SE | 1 |
| Hanania, NA; Lavoie, K; Müllerová, H; Rennard, SI; Tal-Singer, R; Vestbo, J; Wouters, EF; Yohannes, AM | 1 |
| Cai, Y; Dong, B; Huang, J; Huang, Y; Liu, Q; Pan, J; Sha, J; Shao, X; Wang, Y; Wang, Z; Xu, F; Xue, W; Yin, W; Zhu, Y | 1 |
| Gryn', NV; Klys', YG; Verevka, SV | 1 |
| Chung, YC; Feierman, E; Kruyer, A; Norris, EH; Richards, A; Strickland, S; Yao, Y | 1 |
| Aksamija, G; Radovic, S; Rasic, I | 1 |
| Ito, M; Kaneko, H; Nanami, T; Oshima, Y; Shimada, H; Suzuki, T; Washizawa, N; Yajima, S | 1 |
| Amir, AZ; Avitzur, Y; Cattral, M; Cutz, E; De Angelis, M; Fecteau, A; Ghanekar, A; Grant, D; Jones, N; Kamath, B; Ling, SC; Nalli, N; Naqvi, A; Ng, V; Weitzman, S | 1 |
| Donner, L; Elvers, M; Fälker, K; Gohlke, H; Gremer, L; Grenegard, M; Klinker, S; Ljungberg, LU; Lothmann, K; Pagani, G; Rizzi, F; Schaller, M; Willbold, D | 1 |
| Barinas-Mitchell, EJ; Chang, CC; El Khoudary, SR; Matthews, KA; Wang, NC | 1 |
| Amdur, RL; Balakrishnan, VS; Feldman, HI; Go, AS; Gupta, J; He, J; Joffe, M; Kanetsky, P; Kimmel, PL; Kusek, JW; Lash, JP; Ojo, A; Rahman, M; Raj, DS; Roy-Chaudhury, A; Shlipak, M; Townsend, RR; Yang, W | 1 |
| Csuka, D; Czaller, I; Farkas, H; Imreh, É; Takács, E; Varga, L; Veszeli, N; Zotter, Z | 1 |
| Hu, F; Li, C; Xue, Y; Yao, Q; Yu, X; Zhang, H | 1 |
| Agusti, A; Halpin, D; Martinez, FJ; Roche, N; Singh, D; Wedzicha, JA | 1 |
| Arigami, T; Ishigami, S; Kijima, T; Kijima, Y; Kita, Y; Kurahara, H; Maemura, K; Mori, S; Natsugoe, S; Okumura, H; Owaki, T; Uchikado, Y; Uenosono, Y | 1 |
| Chung, J; Gu, J; Kim, H; Kim, HK; Kim, JE; Koh, Y; Lee, N; Yoo, HJ | 1 |
| Bruno, NE; D'Alessandro-Gabazza, CN; Gabazza, EC; Mizoguchi, A; Morser, J; Qin, L; Sumida, Y; Suzuki, K; Suzuki, T; Taguchi, O; Takei, Y; Yano, Y | 1 |
| Funatsu, H; Hori, S; Mimura, T; Noma, H; Shimizu, E | 1 |
| Gotsman, I; Lapidus, L; Lotan, C; Masrawa, S; Novikov, Y; Planer, D; Pugatsch, T; Soskolne, A; Stabholz, A | 1 |
| Artamonov, I; Berliner, S; Drory, VE; Ish-Shalom, M; Keizman, D; Maimon, N; Nefussy, B; Rogowski, O | 1 |
| Aragoncillo, I; de Vinuesa, SG; Goicoechea, M; Gómez-Campderá, F; Luño, J; Mosse, A; Verdalles, U | 1 |
| Hamer, M; Molloy, GJ; Stamatakis, E | 1 |
| Astor, BC; Bash, LD; Coresh, J; Erlinger, TP; Folsom, AR; Marsh-Manzi, J | 1 |
| Daniil, ZD; Germenis, A; Gourgoulianis, KI; Kiropoulos, TS; Kostikas, K; Koutsokera, A; Nikoulis, DJ; Papaioannou, AI; Tanou, K; Tsolaki, V | 1 |
| Carvalho, Mda G; Carvalho, PC; da Fonseca, CO; Domont, GB; Fischer, Jde S; Neves-Ferreira, AG; Perales, J | 1 |
| Rifkin, DE; Sarnak, MJ | 1 |
| Gibikote, S; Kumar, S; Moses, PD; Puliyel, MM; Rose, W | 1 |
| Harada, S; Hosomi, A; Kasai, T; Kuriyama, N; Mizuno, T; Nagakane, Y; Nakagawa, M; Ohara, T; Ozasa, K; Takeda, K; Tokuda, T; Watanabe, Y; Yamada, K | 1 |
| Mittal, RS; Saggar, V; Vyas, MC | 1 |
| Chan, C; Green, D; Jenny, NS; Kang, J; Liu, K; Schreiner, P; Tracy, RP | 1 |
| Kinney, GL; Maahs, DM; Rewers, M; Rodrigues, TC; Snell-Bergeon, JK | 1 |
| Hardison, RM; McBane, RD; Sobel, BE | 1 |
| Hidaka, S; Honda, K; Ikee, R; Ishioka, K; Kobayashi, S; Maesato, K; Mano, T; Moriya, H; Ohtake, T; Oka, M | 1 |
| Amato, A; Cini, M; Conti, E; Favaretto, E; Legnani, C; Palareti, G; Sartori, M | 1 |
| Chung, WS; Ihm, SH; Kim, DB; Kim, HY; Kim, JH; Lee, JM; Park, CS; Seung, KB; Yoo, KD | 1 |
| Gluszko, P; Krawiec, P; Kwasny-Krochin, B; Undas, A | 1 |
| Chen, Y; Fei, L; Fu, X; Guo, G; Guo, S; Wu, S; Wu, Y; Yang, C | 1 |
| Jin, T; Josefsson, E; Kwieciński, J | 1 |
| Bult, H; Emmerechts, J; Fransen, P; Hemmeryckx, B; Hoylaerts, MF; Kauskot, A; Lijnen, HR; Van Hove, CE | 1 |
| Brayne, C; Drew, D; Garwood, C; Ince, PG; Matthews, FE; Savva, GM; Shaw, PJ; Simpson, JE; Viggars, AP; Wharton, SB | 1 |
| Ayres, MC; Azevedo, V; Bastos, BL; de Burghgrave, US; Guedes, MT; Guimarães, JE; Meyer, R; Moura-Costa, LF; Portela, RW; Sena, L | 1 |
| Bagci, U; Caban, JJ; Mollura, DJ; Yao, J | 1 |
| Tanriverdı, O | 1 |
| Díaz, PO; Dreyse, DJ; Gaggero, BA; Lisboa, BC; Saldías, PF; Sandoval, AC | 1 |
| Demidova, VS; Doguzhieva, RM; Lebedeva, AN; Pokrovskiĭ, AV | 1 |
| Guo, YJ; He, B; Li, GY; Li, YS; Lin, TS; Tang, XF; Tong, WS; Xu, JF; Yang, WJ; Yu, H; Zeng, JS; Zheng, P | 1 |
| Ding, Y; Dornbos, D; Ji, X; Li, G; Li, S; Liu, Y; Meng, L; Meng, R; Sun, F; Wang, X; Wu, Y | 1 |
| Blackbourne, LH; Cortez, DS; Dubick, MA; Martini, WZ | 1 |
| Dickens, J; Duvoix, A; Haq, I; Lomas, DA; Mannino, D; Miller, B; Tal-Singer, R | 1 |
| Hu, X; Jin, B; Li, H; Liu, Y; Luo, Y; Qu, X; Teng, Y; Yu, P; Zhang, J; Zhang, L; Zhao, J; Zhao, M; Zheng, S; Zhou, Q | 1 |
| DeClerck, YA; Fang, H; Placencio, VR | 1 |
| Al-Mudhaffer, S; Donnelly, S; Kenny, D; MacMullan, PA; Madigan, A; McCarthy, CJ; McCarthy, EM; McCarthy, GM; Molloy, ES | 1 |
| Dounousi, E; Ioannou, K; Katopodis, K; Kelesidis, A; Koliousi, E; Papagianni, A; Siamopoulos, KC; Tsakiris, D; Zikou, X | 1 |
| Bachmann, E; Schardt, FW; Schmausser, B | 1 |
| Bosevska, G; Bosevski, M; Stojanovska, L | 1 |
| De Maat, MP; Gijbels, MJ; Offerman, EH; Rezaee, F; van der Linden, M; Verheijen, JH | 1 |
| Buggle, F; Grau, AJ; Mansmann, U; Marquardt, L; Mayer, H; Ruf, A; Schuler, M; Winter, R | 1 |
| Chmiel, G; Drozdz, M; Klimeczek, P; Konieczyńska, M; Kowalczyk-Michałek, M; Kraśniak, A; Pasowicz, M; Podolec, P; Sułowicz, W; Szumilak, D; Tracz, W; Wicher-Muniak, E | 1 |
| Bargero, G; Biggeri, A; Bruno, G; Cavallo Perin, P; Ferrero, S; Merletti, F; Pagano, G | 1 |
| Chew, EY | 1 |
| Audebert, HJ; Haberl, RL; Pellkofer, TS; Wimmer, ML | 1 |
| Alderman, EL; Howard, BV; Hsia, J; Lindsay, J; Ouyang, P; Silverman, A; Tripputi, M; Van Voorhees, L; Waters, DD | 1 |
| Janowska-Wieczorek, A; Kijowski, J; Machalinski, B; Marquez-Curtis, L; Ratajczak, J; Ratajczak, MZ; Wysoczynski, M | 1 |
| Diamandis, EP; Ghosh, M; Magklara, A; Michael, IP; Pampalakis, G; Sotiropoulou, G; Wasney, G | 1 |
| Boccio, A; Godoy, DA | 1 |
| Ansquer, JC; Foucher, C; Rattier, S; Steiner, G; Taskinen, MR | 1 |
| Daniel, M; Kaplan, GA; Kaufman, JS; Lynch, JW; Pollitt, RA; Salonen, JT | 1 |
| Amighi, J; Exner, M; Maurer, G; Minar, E; Mlekusch, W; Quehenberger, P; Rumpold, H; Sabeti, S; Schillinger, M; Wagner, O | 1 |
| Awaga, Y; Furuichi, Y; Ichise, R; Maeda, M; Matsuoka, N; Nishimura, S; Noda, A; Takamatsu, H; Tatsumi, M; Yamamoto, M | 1 |
| Esmon, CT; Esmon, NL; Ferrell, GL; Gu, J; Hunter, J; Li, W; Lupu, F; Zheng, X | 1 |
| Couchard, M; Jensen, AH; Muller, P; Relier, JP; Zamet, P | 1 |
| Baskol, M; Dundar, M; Fahrettin, K; Gursoy, S; Kelestimur, F; Kula, M; Mevlut, B; Munis, D; Mustafa, K; Omer, O; Ozbakir, O; Sav, T; Sebnem, G; Tansu, S | 1 |
| Behrens, T; Dasch, B; Fobker, M; Fuhs, A; Hense, HW; Meister, A; Pauleikhoff, D; Wellmann, J | 1 |
| Mora, C; Navarro, JF | 1 |
| Fowkes, FG; Lee, AJ; Lowe, GD; Murray, GD; Price, JF; Rumley, A; Smith, FB; Tzoulaki, I | 1 |
| Bonura, F; Corrado, E; Muratori, I; Novo, S; Rizzo, M; Tantillo, R; Vitale, G | 1 |
| Levy, G; Luo, XP; Ning, Q; Tian, DY; Xi, D; Yan, WM; Zhu, CL; Zhu, F; Zhu, YF | 1 |
| Beilby, JP; Chapman, CM; Hung, J; McQuillan, BM; Thompson, PL | 1 |
| Festa, A; Haffner, SM; Tracy, RP; Wagenknecht, LE; Williams, K | 1 |
| Dichgans, M; Gschwendtner, A; Herzog, J; Holtmannspötter, M; Opherk, C; Peters, N; Sämann, P | 1 |
| Bogavac-Stanojević, N; Jelić-Ivanović, Z; Kalimanovska-Ostrić, D; Memon, L; Spasić, S; Spasojević-Kalimanovska, V; Topić, A | 1 |
| Barberato, SH; Fuerbringer, R; Gonçalves, S; Lima, EG; Pecoits-Filho, R; Perreto, S; Riella, MC; Sauthier, SM; Stinghen, AE | 1 |
| Bevelacqua, V; Curatolo, S; Gangemi, P; La Greca, S; Libra, M; Malaponte, G; Massimino, D; Mazzarino, MC; Merito, P; Nicotra, G; Plumari, A; Stivala, F; Valente, G | 1 |
| Eggebrecht, H; Erbel, R; Fahy, M; Hartmann, M; Louwerenburg, HW; Mintz, GS; Neumann, T; Stoel, MG; van der Palen, J; Verhorst, PM; von Birgelen, C; Wieneke, H | 1 |
| Bickel, C; Blankenberg, S; Cambien, F; Lackner, KJ; Morange, PE; Nicaud, V; Peetz, D; Rupprecht, HJ; Schnabel, R; Tiret, L | 1 |
| Fosse, E; Heuch, I; Jacobsen, BK; Jenssen, T; Joakimsen, O; Johnsen, SH; Jørgensen, L; Mathiesen, EB | 1 |
| Frisbie, JH | 1 |
| Abbate, M; Banfi, C; Bellosta, S; Brioschi, M; Canavesi, M; Gelosa, P; Gianella, A; Guerrini, U; Mussoni, L; Nobili, E; Remuzzi, G; Rottoli, D; Sironi, L; Tremoli, E; Zoja, C | 1 |
| Fujita, T | 1 |
| Melchor, JP; Paul, J; Strickland, S | 1 |
| Bachoo, P; Brittenden, J; Ford, I; Greaves, M; Mckay, I; Rajagopalan, S | 1 |
| Fan, X; Liu, X; Xu, G; Zhang, H; Zhang, S | 1 |
| Ikeuchi, S; Isobe, Y; Kitagawa, Y; Kitajima, M; Kubochi, K; Matsumoto, S; Oishi, T; Shimada, A; Takeuchi, H | 1 |
| Groenewegen, KH; Hop, WC; Postma, DS; Schlösser, NJ; Wielders, PL; Wouters, EF | 1 |
| Ben Assayag, E; Berliner, S; Bornstein, NM; Bova, I; Cohen, M; Shapira, I; Shenhar-Tsarfaty, S; Shopin, L | 1 |
| Colak, B; Deger, SM; Dogan, I; Elbek, S; Gurlek, B; Guz, G; Ozturk, MA; Pasaoglu, H; Unal, S; Yegin, ZA | 1 |
| Egger, G; Jarosch, E; Kiechl, S; Mair, A; Oberhollenzer, F; Santer, P; Willeit, J | 1 |
| de Faire, U; Ericsson, CG; Grip, L; Hamsten, A; Nilsson, J; Svane, B | 1 |
| Poredos, P; Zizek, B | 1 |
| Franks, PJ; Greenhalgh, RM; MacSweeney, ST; Powell, JT; Worrell, P | 1 |
| Ewald, U; Sandhagen, B; Tuvemo, T | 1 |
| Ruggeri, ZM | 1 |
| Bruschke, AV; de Maat, MP; Groenemeier, B; Jansen, H; Jukema, JW; Kastelein, JJ; Kluft, C; Zwinderman, AH | 1 |
| Danielsen, R; Morrissey, JH; Onundarson, PT; Thors, H; Vidarsson, B | 1 |
| Blann, AD; McCollum, CN; Miller, JP; Seigneur, M; Steiner, M | 1 |
| Geerards, S; Meijer, K; Smid, WM; van der Meer, J | 1 |
| Fowkes, FG; Lee, AJ; Leng, GC; Lowe, GD; Rumley, A; Smith, FB | 1 |
| Nagai, N; Takada, A; Takada, Y; Takahashi, H; Urano, T | 1 |
| Adány, R; Bárdos, H; Juhász, A; Répássy, G | 1 |
| Gravanis, MB; Noguchi, S; Numano, F; Wilcox, JN | 1 |
| Grigor'eva, EV; Kaminskaia, GO; Testov, VV | 1 |
| Dernellis, J; Diamantopoulos, L; Stefanadi, E; Stefanadis, C; Toutouzas, K; Toutouzas, P; Tsiamis, E; Vlachopoulos, C | 1 |
| Falk, E; Ravn, HB | 1 |
| Ferrario, F; Napodano, P; Rastaldi, MP | 1 |
| Fazekas, F; Hartung, HP; Kapeller, P; Schmidt, H; Schmidt, R | 1 |
| Fowkes, FG; Hau, CM; Lee, AJ; Lowe, GD; Rumley, A; Smith, FB | 1 |
| Heilmann, L; Hommel, G; Nieman, F; von Tempelhoff, GF | 1 |
| Hetzel, J; Hoffmeister, A; Hombach, V; Koenig, W; Kron, M; Sander, S | 1 |
| Naito, M | 1 |
| Applegate, WB; Chesney, CM; Davis, KB; Elam, MB; Garg, R; Herd, JA; Hunninghake, D; Kennedy, JW | 1 |
| Castillo, J; Chamorro, A; Dávalos, A; Vila, N | 1 |
| Katamine, S; Kohno, T; Matsuyama, T; Moriuchi, R; Tomonaga, M; Yamada, Y | 1 |
| Eitzman, DT; Ginsburg, D; Tyson, J; Westrick, RJ; Xu, Z | 1 |
| Kristensson, K; Mhlanga, JD; Mulenga, C; Robertson, B | 1 |
| Brown, LC; Brull, DJ; Greenhalgh, RM; Humphries, SE; Jones, KG; Powell, JT; Sian, M | 1 |
| Abdullaev, RIu; Kaminskaia, GO; Martynova, EV; Serebrianaia, BA | 1 |
| Matsui, Y; Shiigai, T; Shintani, S | 1 |
13 review(s) available for fibrinogen and Disease Exacerbation
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Mechanisms of coronary thrombosis in cigarette smoke exposure.
Topics: Animals; Coronary Thrombosis; Coronary Vessels; Disease Progression; Endothelium, Vascular; Fibrinogen; Hemostasis; Humans; Inflammation Mediators; Oxidative Stress; Plaque, Atherosclerotic; Platelet Activation; Prognosis; Risk Assessment; Risk Factors; Smoking; Thromboplastin; Tobacco Smoke Pollution; Tobacco Use Disorder | 2013 |
The Northwick Park Heart Study: evidence from the laboratory.
Topics: Antigens; Atherosclerosis; Blood Coagulation; Coronary Disease; Disease Progression; Factor VII; Fibrinogen; Hemostasis; Humans; Inflammation; Phenotype; Prospective Studies; Risk Factors; Thrombosis | 2014 |
Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration.
Topics: Atherosclerosis; Biomarkers; C-Reactive Protein; Carotid Intima-Media Thickness; Disease Progression; Fibrinogen; Humans; Inflammation; Leukocyte Count | 2016 |
Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis.
Topics: Disease Progression; Disease-Free Survival; Fibrinogen; Humans; Neoplasms; Prognosis; Proportional Hazards Models | 2015 |
Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease.
Topics: Biomarkers; Disease Progression; Fibrinogen; Humans; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index | 2013 |
Epidemiology of diabetic retinopathy.
Topics: Anemia; Diabetic Retinopathy; Disease Progression; Fibrinogen; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Risk Factors; Serum Albumin | 2003 |
The role of inflammation as a pathogenic factor in the development of renal disease in diabetes.
Topics: Animals; Biomarkers; C-Reactive Protein; Cytokines; Diabetic Nephropathies; Disease Progression; Fibrinogen; Humans; Inflammation; Prognosis; Serum Amyloid A Protein | 2005 |
Mechanisms initiating platelet thrombus formation.
Topics: Biomechanical Phenomena; Blood Flow Velocity; Disease Progression; Fibrinogen; Humans; Platelet Adhesiveness; Platelet Aggregation; Thrombosis; von Willebrand Factor | 1997 |
-455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute-phase reaction pattern of fibrinogen. REGRESS group.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Fibrinogen; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic | 1998 |
Histopathology of plaque rupture.
Topics: Biomechanical Phenomena; Coronary Artery Disease; Coronary Vessels; Disease Progression; Fibrinogen; Humans; Immunochemistry; Metalloendopeptidases; Rupture, Spontaneous | 1999 |
Morphological features in IgA nephropathy.
Topics: Biopsy; Disease Progression; Fibrinogen; Fibrosis; Glomerulonephritis, IGA; Humans; Immunohistochemistry; In Situ Hybridization; Inflammation; Microscopy, Electron; Monocytes; Necrosis; Severity of Illness Index; Vascular Cell Adhesion Molecule-1 | 1999 |
[Effects of fibrinogen, fibrin and their degradation products on the behaviour of vascular smooth muscle cells].
Topics: Animals; Arteriosclerosis; Cell Movement; Disease Progression; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Muscle, Smooth, Vascular; Rabbits | 2000 |
16 trial(s) available for fibrinogen and Disease Exacerbation
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.
Topics: Aged; Biomarkers; Bronchodilator Agents; Disease Progression; Double-Blind Method; Drug Combinations; Female; Fibrinogen; Humans; Lung; Male; Middle Aged; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Time Factors; Treatment Outcome; Up-Regulation | 2021 |
Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.
Topics: Antibody Specificity; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Disease Progression; Drug Therapy, Combination; Female; Fibrinogen; Humans; Hydroxychloroquine; Infliximab; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Phosphopyruvate Hydratase; Radiography; Sulfasalazine; Sweden; Vimentin | 2016 |
Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).
Topics: Age Factors; Aged; Autoantigens; Coronary Artery Disease; Diabetes Mellitus, Type 2; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Follow-Up Studies; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Retrospective Studies; Risk Factors; Severity of Illness Index; Time Factors; Tissue Plasminogen Activator | 2010 |
Course of platelet activation markers after ischemic stroke.
Topics: Aged; Antigens, CD; Biomarkers; Blood Platelets; Brain Ischemia; C-Reactive Protein; Cell Adhesion Molecules; Disease Progression; Female; Fibrinogen; Flow Cytometry; Humans; Leukocyte Count; Male; Middle Aged; Observer Variation; P-Selectin; Platelet Activation; Platelet Membrane Glycoproteins; Reference Values; Risk Factors; Stroke; Tetraspanin 30 | 2002 |
[Evaluation of atherosclerosis progression in patients treated repeatedly with hemodialysis].
Topics: Adult; Aged; Arteries; Arteriosclerosis; Calcium; Cholesterol, LDL; Disease Progression; Female; Fibrinogen; Homocysteine; Humans; Kidney Diseases; Male; Middle Aged; Phosphates; Renal Dialysis; Ultrasonography | 2002 |
Postmenopausal hormone therapy is associated with atherosclerosis progression in women with abnormal glucose tolerance.
Topics: Adult; Aged; Blood Glucose; C-Reactive Protein; Canada; Comorbidity; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Disease Progression; Drug Combinations; Estrogens, Conjugated (USP); Female; Fibrinogen; Follow-Up Studies; Glucose Intolerance; Hormone Replacement Therapy; Humans; Hysterectomy; Inflammation; Insulin; Insulin Resistance; Lipoproteins, HDL; Medroxyprogesterone Acetate; Middle Aged; Obesity; Postmenopause; Prospective Studies; Single-Blind Method; Triglycerides; United States | 2004 |
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Fenofibrate; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Incidence; Male; Middle Aged; Models, Biological; Smoking; Treatment Outcome | 2005 |
Increased systemic inflammation is a risk factor for COPD exacerbations.
Topics: Aged; Anti-Inflammatory Agents; C-Reactive Protein; Disease Progression; Female; Fibrinogen; Forced Expiratory Volume; Functional Residual Capacity; Humans; Inflammation; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Prednisolone; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk Factors; Tumor Necrosis Factors | 2008 |
Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study.
Topics: Adult; Aged; Alcohol Drinking; Antithrombin III; Arteriosclerosis; Carotid Artery Diseases; Carotid Stenosis; Disease Progression; Estrogen Replacement Therapy; Female; Fibrinogen; Forecasting; Humans; Italy; Lipoprotein(a); Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Factors; Ultrasonography | 1995 |
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients.
Topics: Adult; Apolipoproteins; Bezafibrate; Cholesterol; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Feasibility Studies; Fibrinogen; Humans; Hypolipidemic Agents; Male; Myocardial Infarction; Risk Factors; Time Factors; Triglycerides | 1996 |
-455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute-phase reaction pattern of fibrinogen. REGRESS group.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Fibrinogen; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic | 1998 |
Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Cardiac Catheterization; Cholesterol; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Coronary Thrombosis; Disease Progression; Factor VII; Factor VIIa; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Prospective Studies; Regression Analysis; Risk Assessment; Sex Characteristics; Triglycerides | 1998 |
Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT).
Topics: Aged; Anticoagulants; Antioxidants; Arterial Occlusive Diseases; Ascorbic Acid; beta Carotene; Blood Coagulation; Disease Progression; Drug Therapy, Combination; Feasibility Studies; Female; Fibrinogen; Humans; Male; Niacin; Vitamin E; von Willebrand Factor; Warfarin | 2000 |
Proinflammatory cytokines and early neurological worsening in ischemic stroke.
Topics: Aged; Biomarkers; Blood Glucose; Body Temperature; Brain Ischemia; Cohort Studies; Disease Progression; Female; Fibrinogen; Humans; Interleukin-6; Male; Multivariate Analysis; Predictive Value of Tests; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric; Stroke; Tumor Necrosis Factor-alpha | 2000 |
Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms.
Topics: Aged; Alleles; Aortic Aneurysm, Abdominal; Blood Pressure; Brachial Artery; C-Reactive Protein; Disease Progression; Electrocardiography; Female; Fibrinogen; Follow-Up Studies; Genotype; Humans; Iliac Artery; Interleukin-6; Male; Middle Aged; Polymorphism, Genetic; Predictive Value of Tests; Prognosis; Promoter Regions, Genetic; Survival Rate; Tomography, X-Ray Computed | 2001 |
189 other study(ies) available for fibrinogen and Disease Exacerbation
| Article | Year |
|---|---|
Inflammation/coagulopathy/fibrinolysis: Dynamic indicators of COVID-19 progression in patients with moderate COVID-19 in Wenzhou, China.
Topics: Adult; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; China; COVID-19; Disease Progression; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Inflammation; Male; Middle Aged; Prothrombin Time; SARS-CoV-2 | 2021 |
Inflammatory indices obtained from routine blood tests show an inflammatory state associated with disease progression in engineered stone silicosis patients.
Topics: Adult; Biomarkers; Blood Cell Count; Disease Progression; Dust; Fibrinogen; Humans; Inflammation; L-Lactate Dehydrogenase; Male; Pneumoconiosis; Silicosis | 2022 |
Brain proteome profiling implicates the complement and coagulation cascade in multiple system atrophy brain pathology.
Topics: Brain; Chromatography, Liquid; Cross-Sectional Studies; Disease Progression; Fibrinogen; Glial Fibrillary Acidic Protein; Humans; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Proteome; Tandem Mass Spectrometry | 2022 |
Prognostic value of the albumin-to-fibrinogen ratio (AFR) in IgA nephropathy patients.
Topics: Albumins; Disease Progression; Fibrinogen; Glomerulonephritis, IGA; Humans; Kidney Failure, Chronic; Prognosis; Retrospective Studies | 2022 |
COVID-19 in elderly: Correlations of viral load, clinical course, laboratory parameters, among patients vaccinated with CoronaVac.
Topics: Aged; Aged, 80 and over; COVID-19; Disease Progression; Fibrinogen; Humans; Middle Aged; SARS-CoV-2; Viral Load | 2022 |
Glomerular deposition of fibrinogen predicts good prognosis of IgA nephropathy: a single-center cohort study.
Topics: Adult; Cohort Studies; Disease Progression; Fibrinogen; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Prognosis; Reproducibility of Results; Retrospective Studies | 2023 |
Albumin-to-fibrinogen ratio is an independent predictor of corticosteroid response and prognosis in patients with IgA nephropathy.
Topics: Adrenal Cortex Hormones; Albumins; Disease Progression; Fibrinogen; Glomerular Filtration Rate; Glomerulonephritis, IGA; Hemostatics; Humans; Prognosis; Retrospective Studies | 2023 |
The role of IL-6, ferritin, and coagulopathy in Covid-19 clinical progression.
Topics: Blood Coagulation Disorders; COVID-19; Disease Progression; Ferritins; Fibrinogen; Humans; Interleukin-6; Prospective Studies; SARS-CoV-2 | 2022 |
FGA isoform as an indicator of targeted therapy for EGFR mutated lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Disease Progression; Drug Resistance, Neoplasm; ErbB Receptors; Female; Fibrinogen; Hepatocytes; Humans; Immunoprecipitation; Lung Neoplasms; Male; Mass Spectrometry; Middle Aged; Molecular Targeted Therapy; Protein Array Analysis; Protein Isoforms; Protein Kinase Inhibitors; Proteomics | 2019 |
Preoperative Plasma Fibrinogen and D-dimer as Prognostic Biomarkers for Non-Muscle-Invasive Bladder Cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cystectomy; Disease Progression; Disease-Free Survival; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Preoperative Period; Prognosis; Progression-Free Survival; Retrospective Studies; Urinary Bladder; Urinary Bladder Neoplasms; Young Adult | 2020 |
Ability of Fibrin Monomers to Predict Progressive Hemorrhagic Injury in Patients with Severe Traumatic Brain Injury.
Topics: Abbreviated Injury Scale; Adult; Blood Coagulation Disorders; Brain Hemorrhage, Traumatic; Brain Injuries, Traumatic; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glasgow Coma Scale; Glasgow Outcome Scale; Hospital Mortality; Humans; International Normalized Ratio; Intracranial Hemorrhages; Male; Middle Aged; Neurosurgical Procedures; Partial Thromboplastin Time; Platelet Count; Prospective Studies; Prothrombin Time; Risk Assessment; Young Adult | 2020 |
Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.
Topics: Aged; Biomarkers; Blood Glucose; Coronary Artery Disease; Diabetes Mellitus; Disease Progression; Fasting; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Middle Aged; Myocardial Revascularization; Prediabetic State; Progression-Free Survival; Risk Assessment; Risk Factors; Time Factors; Up-Regulation | 2020 |
D-dimer/fibrinogen ratio for the prediction of progressive hemorrhagic injury after traumatic brain injury.
Topics: Adult; Brain Injuries, Traumatic; Cohort Studies; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Humans; Male; Prognosis; Retrospective Studies; Risk Factors; ROC Curve | 2020 |
Clinical Outcomes and Inflammatory Responses of the Frequent Exacerbator in Pulmonary Rehabilitation: A Prospective Cohort Study.
Topics: Aged; Antigens, CD; C-Reactive Protein; CD11b Antigen; Cell Adhesion Molecules; Cohort Studies; Disease Progression; Female; Fibrinogen; Forced Expiratory Volume; GPI-Linked Proteins; Humans; Inflammation; L-Selectin; Leukocyte Count; Male; Middle Aged; Neutrophil Activation; Neutrophils; Physical Therapy Modalities; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Surveys and Questionnaires; Vital Capacity; Walk Test | 2020 |
D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis.
Topics: Adult; Aged; Aged, 80 and over; Betacoronavirus; Blood Coagulation Disorders; China; Coronavirus Infections; COVID-19; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lung; Male; Middle Aged; Pandemics; Partial Thromboplastin Time; Pneumonia, Viral; Prognosis; Prothrombin Time; SARS-CoV-2; Thrombin Time; Tomography, X-Ray Computed | 2020 |
Organ Transplantation in Hereditary Fibrinogen A α-Chain Amyloidosis: A Case Series of French Patients.
Topics: Adolescent; Adult; Aged; Amyloidosis, Familial; Child; Combined Modality Therapy; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Frameshift Mutation; France; Genetic Association Studies; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Mutation, Missense; Point Mutation; Renal Dialysis; Treatment Outcome; Young Adult | 2020 |
Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC).
Topics: Aged; Betacoronavirus; Biomarkers; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Disease Progression; Female; Fibrinogen; Host Microbial Interactions; Humans; Leukocyte Count; Longitudinal Studies; Male; Middle Aged; Pandemics; Platelet Count; Pneumonia, Viral; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; SARS-CoV-2; Time Factors | 2020 |
Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19).
Topics: Adult; Aged; Betacoronavirus; Blood Cell Count; Comorbidity; Coronavirus Infections; COVID-19; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Middle Aged; Pandemics; Patient Admission; Plasminogen; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2; Thrombophilia | 2020 |
Inherited risk of dementia and the progression of cerebral small vessel disease and inflammatory markers in cognitively healthy midlife adults: the PREVENT-Dementia study.
Topics: Alzheimer Disease; Apolipoprotein E4; Biomarkers; C-Reactive Protein; Cerebral Small Vessel Diseases; Cognition; Dementia; Disease Progression; Female; Fibrinogen; Genetic Association Studies; Genetic Predisposition to Disease; Healthy Aging; Heterozygote; Humans; Inflammasomes; Male; Middle Aged; Risk; White Matter | 2021 |
Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma.
Topics: B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Chemokine CCL5; Coculture Techniques; Databases, Genetic; Dendritic Cells; Disease Progression; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fibrinogen; Fibroblast Growth Factor 7; Hepatitis A Virus Cellular Receptor 2; Humans; Interleukin-10; Interleukin-13; Lymphocytes, Tumor-Infiltrating; Macrophage Colony-Stimulating Factor; Matrix Metalloproteinase 9; Neutrophils; RNA, Messenger; THP-1 Cells; Tumor Microenvironment; Tumor-Associated Macrophages; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 2020 |
Clinical and predictive significance of Plasma Fibrinogen Concentrations combined Monocyte-lymphocyte ratio in patients with Diabetic Retinopathy.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Fibrinogen; Humans; Leukocyte Count; Lymphocytes; Male; Middle Aged; Monocytes; Predictive Value of Tests; Prognosis; Risk Assessment | 2021 |
The preoperative elevated plasma fibrinogen level is associated with the prognosis of hilar cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Biomarkers; Disease Progression; Female; Fibrinogen; Humans; Klatskin Tumor; Lymphatic Metastasis; Male; Margins of Excision; Middle Aged; Neoplasm Invasiveness; Preoperative Period; Prognosis; Retrospective Studies; Survival Rate | 2021 |
Attempt to Develop Rat Disseminated Intravascular Coagulation Model Using Yamakagashi (
Topics: Animals; Biomarkers; Blood Coagulation; Colubridae; Disease Models, Animal; Disease Progression; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematuria; Male; Rats, Sprague-Dawley; Snake Bites; Snake Venoms; Thrombocytopenia; Time Factors | 2021 |
Combined fibrinogen-to-pre-albumin ratio and carbohydrate antigen 19-9 score is a promising metric to predict progression of metastatic colorectal mucinous adenocarcinoma.
Topics: Adenocarcinoma, Mucinous; CA-19-9 Antigen; Colorectal Neoplasms; Disease Progression; Female; Fibrinogen; Humans; Inflammation; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Prealbumin; Prognosis; Proportional Hazards Models | 2021 |
Plasma D-Dimer and Fibrinogen Levels Correlates with Tumor Size and Disease Progression in Nigerian Breast Cancer Patients.
Topics: Adult; Aged; Breast Neoplasms; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Middle Aged; Nigeria; Prognosis | 2021 |
Cytokine storm in severe COVID-19 pneumonia.
Topics: Aged; Alanine Transaminase; Anemia; Aspartate Aminotransferases; Biomarkers; COVID-19; Cytokine Release Syndrome; Diagnosis, Differential; Disease Progression; Female; Fibrinogen; Humans; Hyperferritinemia; Intensive Care Units; L-Lactate Dehydrogenase; Lymphohistiocytosis, Hemophagocytic; Lymphopenia; Macrophage Activation Syndrome; Male; Middle Aged; Procalcitonin; Retrospective Studies; SARS-CoV-2; Thrombocytopenia; Triglycerides; Troponin | 2021 |
Association Between the Inflammatory Biomarkers and Left Ventricular Systolic Dysfunction in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease.
Topics: Aged; Biomarkers; C-Reactive Protein; Disease Progression; Echocardiography; Female; Fibrinogen; Heart Failure; Humans; Inflammation Mediators; Leukocyte Count; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Serbia; Ventricular Dysfunction, Left; Ventricular Function, Left | 2017 |
ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.
Topics: ADAMTS13 Protein; Albuminuria; Animals; Cell Proliferation; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Extracellular Matrix; Fibrinogen; Genetic Predisposition to Disease; Kidney Glomerulus; Male; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Plasminogen Activator Inhibitor 1; Platelet Membrane Glycoprotein IIb; Streptozocin; Thrombosis; Urea; von Willebrand Factor | 2017 |
Urinary Fibrinogen as a Predictor of Progression of CKD.
Topics: Adult; Area Under Curve; Atrophy; Biomarkers; Blood Pressure; Creatinine; Disease Progression; Female; Fibrinogen; Fibrosis; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Kidney Tubules; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Risk Factors; ROC Curve; Young Adult | 2017 |
Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia - A pilot study from a tertiary center in Northern India.
Topics: Alzheimer Disease; Biomarkers; Brain; C-Reactive Protein; Dementia, Vascular; Diagnosis, Differential; Disease Progression; Fibrinogen; Humans; India; Interleukin-6; Magnetic Resonance Imaging; Pilot Projects; Positron-Emission Tomography; Sensitivity and Specificity | 2017 |
Prognostic role of plasma fibrinogen in patients with uterine leiomyosarcoma - a multicenter study.
Topics: Biomarkers, Tumor; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Grading; Prognosis; Retrospective Studies; Survival Analysis; Tumor Burden; Uterine Neoplasms | 2017 |
Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes.
Topics: Adult; Biomarkers; Blood Coagulation; C-Reactive Protein; Cholesterol; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus, Type 1; Disease Progression; E-Selectin; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Glycated Hemoglobin; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Kidney Diseases; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prospective Studies; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Triglycerides; Vascular Cell Adhesion Molecule-1; Young Adult | 2018 |
[Quality standards for ultrasonographic assessment of peripheral vascular malformations and vascular tumors. Report of the french society for vascular medicine. 2018 Update].
Topics: Adult; Blood Coagulation Disorders; Blood Flow Velocity; Clinical Competence; Disease Progression; Eye Neoplasms; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemangioma; Hemodynamics; Humans; Infant; Lymphangioma, Cystic; Male; Quality Assurance, Health Care; Ultrasonography, Doppler, Color; Ultrasonography, Doppler, Duplex; Vascular Malformations; Vascular Neoplasms | 2018 |
Blood vessel occlusion with erythrocyte aggregates causes burn injury progression-microvasculature dilation as a possible therapy.
Topics: Animals; Apoptosis; Arterial Occlusive Diseases; Burns; Disease Progression; Erythrocyte Aggregation; Fibrinogen; Humans; Inflammation; Ischemia; Microvessels; Necrosis; Peptides; Skin; Vasodilator Agents | 2018 |
Pathologic intimal thickening in human atherosclerosis is formed by extracellular accumulation of plasma-derived lipids and dispersion of intimal smooth muscle cells.
Topics: Adolescent; Adult; Apolipoprotein B-100; Apoptosis; Autopsy; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Fibrinogen; Foam Cells; Humans; Lipids; Male; Middle Aged; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Phenotype; Plaque, Atherosclerotic; Young Adult | 2018 |
Activation of Hepatic Stellate Cells During Liver Carcinogenesis Requires Fibrinogen/Integrin αvβ5 in Zebrafish.
Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Disease Progression; Fibrinogen; Hepatic Stellate Cells; Hepatocytes; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Oncogenes; Receptors, Vitronectin; Signal Transduction; Zebrafish | 2018 |
Serum fibrinogen predicts diabetic ESRD in patients with type 2 diabetes mellitus.
Topics: Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Fibrinogen; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Retrospective Studies | 2018 |
Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function.
Topics: Adult; Animals; CD8-Positive T-Lymphocytes; Cytokines; Disease Models, Animal; Disease Progression; Female; Fibrinogen; Gene Expression; Hepatitis, Autoimmune; Humans; Immunomodulation; Liver Function Tests; Lymphocyte Count; Male; Mice; Middle Aged; T-Lymphocytes, Regulatory | 2018 |
The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.
Topics: Adult; Aged; Aged, 80 and over; Animals; Cell Transformation, Neoplastic; Disease Progression; Fibrinogen; Glioma; Humans; Immunosuppression Therapy; Mice; Mice, Inbred C57BL; Middle Aged; Prognosis; Survival Rate; T-Lymphocytes, Regulatory; Tumor Microenvironment | 2019 |
Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy.
Topics: Adult; Biomarkers; Biopsy; Complement C3; Disease Progression; Female; Fibrinogen; Fluorescent Antibody Technique; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin G; Kidney Failure, Chronic; Kidney Glomerulus; Male; Predictive Value of Tests; Prognosis; Risk Factors; Steroids; Young Adult | 2019 |
Fibrinogen and Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Advanced Hypopharyngeal Squamous Cell Carcinoma.
Topics: Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Carcinoma, Squamous Cell; Decision Support Techniques; Disease Progression; Disease-Free Survival; Female; Fibrinogen; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Multivariate Analysis; Neutrophils; Predictive Value of Tests; Proportional Hazards Models; Reproducibility of Results; Retrospective Studies; Risk Factors; ROC Curve; Squamous Cell Carcinoma of Head and Neck; Time Factors; Treatment Outcome | 2018 |
Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannoma.
Topics: Adult; Aged; Aged, 80 and over; Calcium-Binding Proteins; Capillary Permeability; Carbon Radioisotopes; Case-Control Studies; Disease Progression; Female; Fibrinogen; Humans; Immunohistochemistry; Inflammation; Isoquinolines; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Microfilament Proteins; Middle Aged; Neuroma, Acoustic; Platelet Endothelial Cell Adhesion Molecule-1; Positron-Emission Tomography; Receptors, GABA; S100 Proteins; Tumor Burden | 2019 |
Inflammation as a predictor of disease course in posttraumatic stress disorder and depression: A prospective analysis from the Mind Your Heart Study.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Catecholamines; Cohort Studies; Depression; Depressive Disorder; Disease Progression; Female; Fibrinogen; Humans; Hydrocortisone; Inflammation; Leukocyte Count; Male; Middle Aged; Prognosis; Prospective Studies; Stress Disorders, Post-Traumatic; Veterans | 2019 |
Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Carcinoma, Hepatocellular; Case-Control Studies; Disease Progression; Female; Fibrinogen; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Solubility; Young Adult | 2018 |
The relationship between endothelial function and aortic valve calcification: Multi-Ethnic Study of Atherosclerosis.
Topics: Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Atherosclerosis; Biomarkers; C-Reactive Protein; Calcinosis; Disease Progression; E-Selectin; Endothelium, Vascular; Ethnicity; Female; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Multivariate Analysis; Prevalence; Prospective Studies; Risk Factors | 2019 |
Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?
Topics: Animals; Antibodies, Monoclonal; Arthritis, Experimental; Arthritis, Rheumatoid; Cellular Microenvironment; Collagen; Cytokines; Disease Progression; Fibrinogen; Humans; Immunotherapy; Rats; Synovial Membrane; Tenascin; Toll-Like Receptor 4 | 2019 |
FGL2 promotes tumor progression in the CNS by suppressing CD103
Topics: Animals; Antigens, CD; Brain Neoplasms; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Differentiation; Cell Line, Tumor; Dendritic Cells; Disease Progression; Fibrinogen; Gene Expression Regulation, Neoplastic; Glioblastoma; Heterografts; Humans; Integrin alpha Chains; Mice; Mice, Transgenic; Neoplastic Stem Cells; Neuroglia; NF-kappa B; p38 Mitogen-Activated Protein Kinases; STAT Transcription Factors; Survival Analysis; Tumor Burden | 2019 |
MicroRNA-488 regulates diabetic nephropathy via TGF-β1 pathway.
Topics: Cell Line; Collagen; Diabetic Nephropathies; Disease Progression; Fibrinogen; Fibronectins; Gene Knockdown Techniques; Glucose; Humans; Mesangial Cells; MicroRNAs; Signal Transduction; Transforming Growth Factor beta1 | 2019 |
Fibrinolytic Activation in Patients with Progressive Intracranial Hemorrhage after Traumatic Brain Injury.
Topics: Adult; Aged; Brain Injuries, Traumatic; Disease Progression; Female; Fibrinogen; Fibrinolysis; Glasgow Coma Scale; Humans; Intracranial Hemorrhages; Male; Middle Aged; Prospective Studies; Thrombelastography | 2021 |
The APOE ɛ4/ɛ4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Apolipoprotein E4; Atherosclerosis; Blood Vessels; Brain; Cerebral Amyloid Angiopathy; Disease Progression; Female; Fibrinogen; Genotype; Humans; Immunohistochemistry; Male; Middle Aged; Plaque, Amyloid; Sex Characteristics | 2013 |
The COPD Biomarker Qualification Consortium (CBQC).
Topics: Biomarkers; C-Reactive Protein; Desmosine; Disease Progression; Exercise Test; Fibrinogen; Health Status; Humans; Public-Private Sector Partnerships; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Radiography; Respiratory Function Tests; Respiratory Mechanics; Severity of Illness Index; Sputum; Surveys and Questionnaires; Treatment Outcome; Uteroglobin | 2013 |
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Topics: Adrenal Cortex Hormones; Aged; Anti-Bacterial Agents; Biomarkers; C-Reactive Protein; Disease Progression; Female; Fibrinogen; Forced Expiratory Volume; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Odds Ratio; Patient Admission; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk; Risk Assessment; Severity of Illness Index; Vital Capacity | 2013 |
Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease.
Topics: Aged; Blood Cell Count; Blood Gas Analysis; C-Reactive Protein; Case-Control Studies; Disease Progression; Female; Fibrinogen; Humans; Male; Mean Platelet Volume; Middle Aged; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index | 2013 |
Factors related to the initial stroke severity of posterior circulation ischemic stroke.
Topics: Aged; Blood Glucose; Blood Sedimentation; Brain Damage, Chronic; C-Reactive Protein; Cerebral Angiography; Cerebrovascular Circulation; Comorbidity; Diabetes Mellitus; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Infarction, Posterior Cerebral Artery; Intracranial Embolism; Ischemic Attack, Transient; Leukocyte Count; Male; Middle Aged; Registries; Republic of Korea; Risk; Risk Factors; Severity of Illness Index; Smoking; Symptom Assessment; Treatment Outcome | 2013 |
Combined effects of fibrinogen genetic variability on atherosclerosis in patients with or without stable angina pectoris: focus on the coagulation cascade and endothelial function.
Topics: Angina, Stable; Atherosclerosis; Blood Coagulation; Brachial Artery; Disease Progression; DNA; Endothelium, Vascular; Female; Fibrinogen; Follow-Up Studies; Genotype; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Ultrasonography, Doppler, Pulsed; Vasodilation | 2013 |
The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer.
Topics: Aged; Blood Platelets; Disease Progression; Female; Fibrinogen; Humans; Male; Neoplasm Metastasis; Pancreatic Neoplasms; Prognosis; Risk Factors; Survival Analysis | 2014 |
Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.
Topics: Aged; Aged, 80 and over; Aorta; Blood Pressure; C-Reactive Protein; Cardiomyopathies; Cardiovascular Diseases; Cohort Studies; Disease Progression; Female; Fibrinogen; Heart Rate; Humans; Interleukin-6; Interleukin-8; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulse Wave Analysis; Risk Factors; Spirometry; Sputum; Troponin T; Vascular Stiffness | 2013 |
The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.
Topics: Biomarkers, Tumor; Disease Progression; Disease-Free Survival; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Grading; Nomograms; Preoperative Care; Prognosis; Retrospective Studies; Sarcoma; Survival Rate | 2014 |
Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism.
Topics: Adult; Aged; Aged, 80 and over; Antithrombin III; Blood Coagulation Tests; Carcinoma, Pancreatic Ductal; Case-Control Studies; Cohort Studies; Disease Progression; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; International Normalized Ratio; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Partial Thromboplastin Time; Prognosis; Proportional Hazards Models; Protein C; Prothrombin Time; Retrospective Studies; Venous Thromboembolism | 2015 |
Relationship of coagulation and fibrinolytic variables with arterial structure and function in Africans.
Topics: Africa; Black People; Blood Coagulation; Cardiovascular Diseases; Cohort Studies; Disease Progression; Female; Fibrin Clot Lysis Time; Fibrinogen; Fibrinolysis; Humans; Male; Prospective Studies; Risk Factors | 2014 |
Inflammation and peripheral venous disease. The San Diego Population Study.
Topics: Aged; Biomarkers; C-Reactive Protein; California; Chemokine CCL2; Cytokines; Disease Progression; E-Selectin; Female; Fibrinogen; Humans; Inflammation Mediators; Intercellular Adhesion Molecule-1; Male; Middle Aged; Peripheral Vascular Diseases; Population Groups; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A; Veins | 2014 |
Pharmacological and genetic depletion of fibrinogen protects from kidney fibrosis.
Topics: Ancrod; Animals; Disease Progression; Fibrinogen; Fibrosis; Hep G2 Cells; Humans; Interleukin-6; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Smad2 Protein; STAT3 Transcription Factor; Transforming Growth Factor beta1; Ureteral Obstruction | 2014 |
Overexpression of fibrinogen-like protein 2 induces epithelial-to-mesenchymal transition and promotes tumor progression in colorectal carcinoma.
Topics: Aged; Colon; Colorectal Neoplasms; Disease Progression; Epithelial-Mesenchymal Transition; Female; Fibrinogen; Gene Knockdown Techniques; Humans; Immunohistochemistry; Male; Rectum | 2014 |
A case of congenital afibrinogenemia complicated with thromboembolic events that required repeated amputations.
Topics: Afibrinogenemia; Amputation, Surgical; Anemia; Anticoagulants; Blood Coagulation Tests; Disease Progression; Enoxaparin; Female; Fibrinogen; Foot; Heparin; Humans; Ischemia; Necrosis; Recurrence; Toes; Young Adult | 2015 |
Lack of a 5.9 kDa peptide C-terminal fragment of fibrinogen α chain precedes fibrosis progression in patients with liver disease.
Topics: Disease Progression; Female; Fibrinogen; Hep G2 Cells; Hepacivirus; Hepatitis C; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Male; Middle Aged; Peptide Fragments | 2014 |
Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism.
Topics: Adult; Aged; Aged, 80 and over; Blood Platelets; Cystadenocarcinoma, Serous; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Prevalence; Prognosis; Survival Rate; Venous Thromboembolism | 2015 |
The evaluation of platelet indices and markers of inflammation, coagulation and disease progression in treatment-naïve, asymptomatic HIV-infected individuals.
Topics: Adult; Antigens, CD; Asymptomatic Diseases; Biomarkers; Blood Coagulation; Blood Platelets; Case-Control Studies; CD4 Lymphocyte Count; Cross-Sectional Studies; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; HIV Infections; HIV-1; Humans; Immunity, Innate; Inflammation; Male; Mean Platelet Volume; Middle Aged; Platelet Activation; Platelet Count; T-Lymphocytes; Thrombosis; Viral Load | 2015 |
Progression of cardiovascular risk factors in black Africans: 3 year follow up of the SABPA cohort study.
Topics: Adult; Black People; Blood Glucose; Cardiovascular Diseases; Cholesterol; Cohort Studies; Diastole; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; South Africa; Systole; Waist Circumference | 2015 |
The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients.
Topics: Aged; Austria; Biomarkers, Tumor; Disease Progression; Disease-Free Survival; Fibrinogen; Follow-Up Studies; Humans; Male; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; Radiotherapy, Conformal; Retrospective Studies; ROC Curve; Survival Rate | 2015 |
Enhanced expression of cell-specific surface antigens on endothelial microparticles in sepsis-induced disseminated intravascular coagulation.
Topics: Adult; Aged; Algorithms; Antigens, CD; Antigens, Surface; Case-Control Studies; Cell-Derived Microparticles; Cross-Sectional Studies; Disease Progression; Disseminated Intravascular Coagulation; Endothelial Protein C Receptor; Endothelium; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Flow Cytometry; Gene Expression Regulation; Humans; Intensive Care Units; Interleukin-6; Male; Middle Aged; Receptors, Cell Surface; Sepsis; Surface Properties; Thrombomodulin; Thromboplastin; Time Factors | 2015 |
Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.
Topics: Aged; Area Under Curve; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Disease Progression; Drug Monitoring; Female; Fibrinogen; Humans; Inflammation Mediators; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Receptors, Urokinase Plasminogen Activator; Retrospective Studies; ROC Curve; Time Factors; Treatment Outcome; Up-Regulation | 2015 |
The clinical significance of preoperative plasma fibrinogen level and platelet count in resectable esophageal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease Progression; Esophageal Neoplasms; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Platelet Count; Preoperative Care; Prognosis; Survival Rate | 2015 |
Modeling the Disease Course of Zaire ebolavirus Infection in the Outbred Guinea Pig.
Topics: Animals; Blood Coagulation; Cell Line; Chlorocebus aethiops; Cytokines; Democratic Republic of the Congo; Disease Models, Animal; Disease Progression; Ebolavirus; Female; Fibrin; Fibrinogen; Guinea Pigs; Hemorrhagic Fever, Ebola; Lymphocytes; Macrophages; Primates; Protein C; Vero Cells | 2015 |
Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and Fibrinogen.
Topics: Adenocarcinoma; Afibrinogenemia; Animals; Cell Division; Cell Line, Tumor; Colonic Neoplasms; Disease Progression; Female; Fibrinogen; HCT116 Cells; Heterografts; Humans; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Prothrombin; Receptor, PAR-1; Stromal Cells; Thrombin; Tumor Burden; Tumor Microenvironment | 2015 |
Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chi-Square Distribution; China; Disease Progression; Disease-Free Survival; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2015 |
Potential effects of vildagliptin on biomarkers associated with prothrombosis in diabetes mellitus.
Topics: Adamantane; Administration, Oral; Animals; Biomarkers; Diabetes Mellitus, Experimental; Disease Progression; Drug Therapy, Combination; Fibrinogen; Hypoglycemic Agents; Male; Nitriles; Pioglitazone; Platelet Count; Pyrrolidines; Rats; Rats, Sprague-Dawley; Streptozocin; Thiazolidinediones; Thrombosis; Vildagliptin | 2015 |
The NLRP3 Inflammasome and IL-1β Accelerate Immunologically Mediated Pathology in Experimental Viral Fulminant Hepatitis.
Topics: Animals; Carrier Proteins; Coronavirus Infections; Disease Progression; Fibrinogen; Host-Pathogen Interactions; Immunity, Innate; Inflammasomes; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Liver; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Murine hepatitis virus; NLR Family, Pyrin Domain-Containing 3 Protein; RAW 264.7 Cells; Reactive Oxygen Species; Receptors, Interleukin-1 Type I; Recombinant Proteins; Signal Transduction; Survival Analysis | 2015 |
Analysis of the Fibrinogen and Neutrophil-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Disease Progression; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fibrinogen; Humans; Lymphocytes; Male; Neutrophils; Prognosis | 2015 |
Inflammatory Markers and Procoagulants in Chronic Renal Disease Stages 1-4.
Topics: Adult; Antithrombin III; C-Reactive Protein; Creatinine; Disease Progression; Factor VII; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Leukocyte Count; Prospective Studies; Renal Insufficiency, Chronic; Serum Albumin; Severity of Illness Index | 2015 |
Simple blood tests as predictive markers of disease severity and clinical condition in patients with venous insufficiency.
Topics: Adult; Biomarkers; Blood Platelets; Chronic Disease; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Leukocyte Count; Lymphocytes; Male; Mean Platelet Volume; Middle Aged; Neutrophils; Platelet Count; Prognosis; Prospective Studies; Sensitivity and Specificity; Serum Albumin; Severity of Illness Index; Venous Insufficiency | 2016 |
Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Autoantibodies; Case-Control Studies; Disease Progression; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Fibrinogen; Humans; Joints; Male; Middle Aged; North America; Peptides, Cyclic; Sweden; Tenascin; United Kingdom | 2016 |
Influence of pre-existing inflammation on the outcome of acute coronary syndrome: a cross-sectional study.
Topics: Acute Coronary Syndrome; Adult; Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Disease Progression; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Platelet Count; Risk Factors; Serum Amyloid A Protein | 2016 |
Preoperative Plasma Fibrinogen Level as a Significant Prognostic Factor in Patients With Localized Renal Cell Carcinoma After Surgical Treatment.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Renal Cell; Disease Progression; Disease-Free Survival; Female; Fibrinogen; Humans; Kidney Neoplasms; Male; Middle Aged; Predictive Value of Tests; Preoperative Period; Prognosis; Retrospective Studies; ROC Curve; Survival Rate; Tumor Burden; Young Adult | 2016 |
Long-term Course of Depression Trajectories in Patients With COPD: A 3-Year Follow-up Analysis of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Cohort.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Chemokines, CC; Cohort Studies; Depression; Depressive Disorder; Disease Progression; Dyspnea; Exercise Test; Fatigue; Female; Fibrinogen; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Sex Factors; Stroke; Uteroglobin | 2016 |
Pretreatment plasma fibrinogen as an independent prognostic indicator of prostate cancer patients treated with androgen deprivation therapy.
Topics: Aged; Androgen Antagonists; Biomarkers, Tumor; Combined Modality Therapy; Disease Progression; Fibrinogen; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Neoplasm Grading; Neoplasm Staging; Prognosis; Prostatic Neoplasms; ROC Curve | 2016 |
Combined use of haemostatic system indices for evaluation of upper respiratory tract cancer progression.
Topics: alpha-Macroglobulins; Blood Coagulation; Blood Coagulation Tests; Disease Progression; Fibrinogen; Hemostasis; Humans; Respiratory System; Respiratory Tract Neoplasms; Thrombin | 2016 |
Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Biotinylation; Brain; Cerebral Amyloid Angiopathy; Dementia, Vascular; Disease Models, Animal; Disease Progression; Fibrin; Fibrinogen; Fibrinolysis; Humans; Hyperhomocysteinemia; Immunohistochemistry; Maze Learning; Memory; Methionine; Mice; Mice, Transgenic; Plaque, Amyloid; Protein Binding | 2016 |
Relationship Between Chronic Inflammation and the Stage and Histopathological Size of Colorectal Carcinoma.
Topics: Aged; Biomarkers, Tumor; Blood Sedimentation; C-Reactive Protein; Carcinoma; Colitis; Colorectal Neoplasms; Cross-Sectional Studies; Disease Progression; Female; Fibrinogen; Humans; Male; Middle Aged; Neoplasm Staging | 2016 |
Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; C-Reactive Protein; Disease Progression; Female; Fibrinogen; Humans; Inflammation Mediators; Male; Middle Aged; Multivariate Analysis; Platelet Count; Preoperative Period; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate | 2016 |
Liver transplantation for children with acute liver failure associated with secondary hemophagocytic lymphohistiocytosis.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Cross-Sectional Studies; Disease Progression; Female; Ferritins; Fibrinogen; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Liver; Liver Failure, Acute; Liver Transplantation; Lymphohistiocytosis, Hemophagocytic; Male; Rare Diseases; Recurrence; Retrospective Studies; Survival Rate; Time-to-Treatment; Treatment Outcome; Triglycerides | 2016 |
Platelets contribute to amyloid-β aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release.
Topics: Adolescent; Adult; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood Platelets; Brain; Cerebrovascular Circulation; Clusterin; Crosses, Genetic; Disease Progression; Female; Fibrinogen; Genotype; Humans; Integrin alpha2; Integrins; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Molecular Dynamics Simulation; Phosphorylation; Platelet Glycoprotein GPIIb-IIIa Complex; Signal Transduction; Young Adult | 2016 |
Inflammatory/Hemostatic Biomarkers and Coronary Artery Calcium Progression in Women at Midlife (from the Study of Women's Health Across the Nation, Heart Study).
Topics: Adult; Antigens; Biomarkers; C-Reactive Protein; Calcinosis; Cohort Studies; Coronary Artery Disease; Coronary Vessels; Disease Progression; Factor VII; Female; Fibrinogen; Humans; Linear Models; Logistic Models; Middle Aged; Plasminogen Activator Inhibitor 1; Prospective Studies; Tissue Plasminogen Activator; Tomography, X-Ray Computed | 2016 |
Inflammation and Progression of CKD: The CRIC Study.
Topics: Adult; Aged; C-Reactive Protein; Cytokines; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Glomerular Filtration Rate; Humans; Inflammation; Interleukin-1; Interleukin-6; Kidney Failure, Chronic; Male; Middle Aged; Renal Insufficiency, Chronic; Serum Albumin; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2016 |
Thyroid hormones and complement parameters in hereditary angioedema with C1-inhibitor deficiency.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoantibodies; Biomarkers; Case-Control Studies; Complement C1 Inhibitor Protein; Complement C4; Complement System Proteins; Danazol; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hereditary Angioedema Types I and II; Humans; Male; Middle Aged; Thyroid Hormones; Young Adult | 2016 |
Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
Topics: Adenocarcinoma; Adult; Aged; Biomarkers, Tumor; Disease Progression; Female; Fibrinogen; Gastrectomy; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Proportional Hazards Models; Retrospective Studies; ROC Curve; Stomach Neoplasms | 2016 |
Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Biomarkers; Bronchodilator Agents; Cardiovascular Diseases; Disease Progression; Drug Therapy, Combination; Fibrinogen; Forced Expiratory Volume; Humans; Muscarinic Antagonists; Phenotype; Precision Medicine; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Severity of Illness Index | 2016 |
Combined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; C-Reactive Protein; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease Progression; Esophageal Neoplasms; Female; Fibrinogen; Humans; Lymphocytes; Male; Middle Aged; Multivariate Analysis; Neutrophils; Prognosis; Reference Values; Retrospective Studies; Serum Albumin | 2017 |
Acquired Dysfibrinogenemia Caused by Autoantibody Inhibiting Fibrin Polymerization in a Patient with MELAS Syndrome and Bleeding Tendency.
Topics: Afibrinogenemia; Autoantibodies; Blood Coagulation Disorders; Disease Progression; Female; Fibrin; Fibrinogen; Humans; Immunoglobulin G; MELAS Syndrome; Middle Aged; Plasma; Polymerization | 2016 |
Immune complex-mediated glomerulonephritis is ameliorated by thrombin-activatable fibrinolysis inhibitor deficiency.
Topics: Animals; Antigen-Antibody Complex; Batroxobin; Carboxypeptidase B2; Complement C3; Cytokines; Disease Models, Animal; Disease Progression; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Fibrosis; Glomerulonephritis; Kidney; Kidney Function Tests; Matrix Metalloproteinases; Mice; Mice, Knockout; Time Factors | 2008 |
Association between serum lipoprotein (a) level and progression of non-proliferative diabetic retinopathy in Type 2 diabetes.
Topics: Aged; Asian People; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Fundus Oculi; Glycated Hemoglobin; Humans; Lipoprotein(a); Male; Middle Aged; Predictive Value of Tests; Risk Assessment; Systole; Time Factors | 2009 |
Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden?
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Interleukins; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Risk Factors; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2008 |
Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Biomarkers; Blood Sedimentation; C-Reactive Protein; Disease Progression; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Prognosis | 2009 |
Serum fibrinogen levels are an independent predictor of mortality in patients with chronic kidney disease (CKD) stages 3 and 4.
Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Chronic Disease; Cross-Sectional Studies; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Kidney Diseases; Longitudinal Studies; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Factors; Severity of Illness Index | 2008 |
Psychological distress as a risk factor for cardiovascular events: pathophysiological and behavioral mechanisms.
Topics: Adult; Alcohol Drinking; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Disease Progression; Female; Fibrinogen; Health Behavior; Humans; Hypertension; Inflammation; Male; Middle Aged; Motor Activity; Obesity; Odds Ratio; Prospective Studies; Psychological Tests; Psychometrics; Risk Factors; Smoking; Stress, Psychological; Surveys and Questionnaires; United Kingdom | 2008 |
Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.
Topics: Biomarkers; Chronic Disease; Cohort Studies; Creatinine; Disease Progression; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Glomerular Filtration Rate; Hemostasis; Humans; Inflammation; Kidney Diseases; Leukocytes; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Serum Albumin; United States; von Willebrand Factor | 2009 |
Clinical, functional and biochemical changes during recovery from COPD exacerbations.
Topics: Aged; Biomarkers; C-Reactive Protein; Disease Progression; Dyspnea; Female; Fibrinogen; Forced Expiratory Volume; Hospitalization; Humans; Interleukin-6; Male; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Serum Amyloid A Protein; Severity of Illness Index; Time Factors; Tumor Necrosis Factors; Vital Capacity | 2009 |
Anti-thrombin as a prognostic biomarker candidate for patients with recurrent glioblastoma multiform under treatment with perillyl alcohol.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Central Nervous System Neoplasms; Disease Progression; Electrophoresis, Polyacrylamide Gel; Fibrin; Fibrinogen; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mass Spectrometry; Monoterpenes; Proteomics; Recurrence | 2008 |
Does inflammation fuel the fire in CKD?
Topics: Biomarkers; C-Reactive Protein; Chronic Disease; Disease Progression; Factor VII; Factor VIII; Fibrinogen; Glomerular Filtration Rate; Humans; Inflammation; Kidney Diseases; Leukocytes; Risk Factors; Serum Albumin; von Willebrand Factor | 2009 |
Prolonged neurologic course of familial hemophagocytic lymphohistiocytosis.
Topics: Aspartic Acid; Bone Marrow; Brain; Child; Choline; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Ferritins; Fibrinogen; Humans; Lactic Acid; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Remission Induction; Siblings; Triglycerides | 2009 |
Evaluation of factors associated with elevated levels of platelet-derived microparticles in the acute phase of cerebral infarction.
Topics: Acute Disease; Aged; Biomarkers; Blood Platelets; C-Reactive Protein; Carotid Artery Diseases; Cell-Derived Microparticles; Cerebral Infarction; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Intracranial Arteriosclerosis; Logistic Models; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Ultrasonography | 2010 |
Hemostatic abnormalities in patients with closed head injuries and their role in predicting early mortality.
Topics: Biomarkers; Blood Coagulation Disorders; Comorbidity; Disease Progression; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Head Injuries, Closed; Mass Screening; Partial Thromboplastin Time; Platelet Count; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Severity of Illness Index; Survival Rate; Time Factors | 2009 |
Longitudinal assessment of fibrinogen in relation to subclinical cardiovascular disease: the CARDIA study.
Topics: Adult; Age Factors; Biomarkers; Black or African American; Calcinosis; Carotid Artery Diseases; Carotid Artery, Common; Coronary Angiography; Coronary Artery Disease; Disease Progression; Female; Fibrinogen; Humans; Linear Models; Logistic Models; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Tomography, X-Ray Computed; Tunica Intima; Tunica Media; Ultrasonography; United States; Up-Regulation; White People | 2010 |
Higher fibrinogen levels predict progression of coronary artery calcification in adults with type 1 diabetes.
Topics: Adult; Calcinosis; Cohort Studies; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus, Type 1; Disease Progression; Female; Fibrinogen; Humans; Male; Middle Aged; Prospective Studies; Risk Factors | 2010 |
Impact of coronary artery calcification in hemodialysis patients: Risk factors and associations with prognosis.
Topics: Aged; C-Reactive Protein; Calcinosis; Calcium; Cohort Studies; Coronary Artery Disease; Cross-Sectional Studies; Disease Progression; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Models, Biological; Prevalence; Prognosis; Prospective Studies; Regression Analysis; Renal Dialysis; Risk Factors; Tomography, X-Ray Computed; Vasculitis | 2010 |
Thrombophilic risk factors and peripheral arterial disease severity.
Topics: Aged; Constriction, Pathologic; Disease Progression; DNA Mutational Analysis; Factor VIII; Female; Fibrinogen; Homocysteine; Humans; Ischemia; Lupus Coagulation Inhibitor; Male; Mutation; Peripheral Arterial Disease; Polymorphism, Genetic; Prothrombin; Risk Factors; Thrombophilia | 2010 |
Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA.
Topics: Adult; Aged; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Disease Progression; Female; Fibrinogen; Homocysteine; Humans; Incidence; Leukocyte Count; Lipoproteins; Male; Middle Aged; Platelet Count; Prognosis; Reference Values; Retrospective Studies; Risk Assessment; Risk Factors; United States | 2010 |
Decreased proteinZ levels in patients with rheumatoid arthritis: links with inflammation.
Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Blood Proteins; C-Reactive Protein; Cholesterol, LDL; Disease Progression; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged | 2011 |
Programmed death (PD)-1-deficient mice are extremely sensitive to murine hepatitis virus strain-3 (MHV-3) infection.
Topics: Animals; Antibodies, Blocking; Disease Models, Animal; Disease Progression; Fibrinogen; Hepatitis, Viral, Animal; Host-Pathogen Interactions; Interferon-gamma; Liver; Lymphoid Tissue; Mice; Mice, Knockout; Murine hepatitis virus; Programmed Cell Death 1 Receptor; Signal Transduction; Survival Rate; Tissue Array Analysis; Tumor Necrosis Factor-alpha | 2011 |
Fibrinolysis is down-regulated in mouse collagen-induced arthritis, but its normalization does not alleviate the course of disease.
Topics: Animals; Arthritis, Rheumatoid; Collagen; Disease Models, Animal; Disease Progression; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Immunohistochemistry; Interleukin-6; Male; Mice; Mice, Inbred DBA; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 2011 |
Progression of the prothrombotic state in aging Bmal1-deficient mice.
Topics: Aging; Aging, Premature; Animals; ARNTL Transcription Factors; Disease Models, Animal; Disease Progression; Endothelium, Vascular; Fibrinogen; Male; Mice; Mice, Knockout; Platelet Count; Prothrombin Time; Thrombomodulin; Thrombosis; von Willebrand Factor | 2011 |
Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: a study in the MRC-CFAS population neuropathology cohort.
Topics: Aged; Aged, 80 and over; Aging; Albumins; Blood-Brain Barrier; Cerebral Cortex; Claudin-5; Claudins; Cohort Studies; Collagen Type IV; Disease Progression; Down-Regulation; Female; Fibrinogen; Humans; Male; Membrane Proteins; Occludin; Phosphoproteins; Statistics, Nonparametric; Zonula Occludens-1 Protein | 2011 |
Haptoglobin and fibrinogen concentrations and leukocyte counts in the clinical investigation of caseous lymphadenitis in sheep.
Topics: Animals; Antibodies, Bacterial; Antigens, Bacterial; Biomarkers; Brazil; Corynebacterium Infections; Corynebacterium pseudotuberculosis; Disease Progression; Female; Fibrinogen; Haptoglobins; Leukocyte Count; Leukocytes; Lymphadenitis; Sheep; Sheep Diseases | 2011 |
Monitoring pulmonary fibrosis by fusing clinical, physiological, and computed tomography features.
Topics: Algorithms; Biomarkers; Blood Sedimentation; Diagnosis, Computer-Assisted; Diagnostic Imaging; Disease Progression; Fibrinogen; Fibrosis; Humans; Image Processing, Computer-Assisted; Lung; Models, Statistical; Pulmonary Fibrosis; Tomography, X-Ray Computed | 2011 |
Association of Helicobacter pylori infection with microalbuminuria in type 2 diabetic patients.
Topics: Adult; Aged; Albuminuria; Blood Sedimentation; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Leukocyte Count; Lipoprotein(a); Logistic Models; Male; Middle Aged; Platelet Count; Statistics, Nonparametric | 2011 |
[Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cohort Studies; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Leukocyte Count; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Sputum | 2012 |
[Hyperhomocysteinemia and plasma acute-phase proteins in patients with type 2 diabetes mellitus and severe course of atherosclerosis after vascular operations].
Topics: Atherosclerosis; C-Reactive Protein; Diabetes Mellitus, Type 2; Disease Progression; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Male; Middle Aged; Postoperative Complications; Risk Assessment; Severity of Illness Index; Statistics as Topic; Vascular Surgical Procedures | 2011 |
Prognosis analysis and risk factors related to progressive intracranial haemorrhage in patients with acute traumatic brain injury.
Topics: Adult; Aged; Antifibrinolytic Agents; Brain Injuries; Cohort Studies; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glasgow Coma Scale; Humans; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Partial Thromboplastin Time; Prognosis; Retrospective Studies; Risk Factors; Thrombin Time; Tomography, X-Ray Computed | 2012 |
Clinical differences between acute CVST and non-thrombotic CVSS.
Topics: Acute Disease; Adult; Angiography, Digital Subtraction; Biomarkers; Blood Cell Count; Brain; Brain Edema; Cerebral Veins; Cerebrovascular Disorders; Constriction, Pathologic; Diagnosis, Differential; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Nervous System Diseases; Prospective Studies; Sinus Thrombosis, Intracranial; Tomography, X-Ray Computed; Young Adult | 2012 |
Different recovery profiles of coagulation factors, thrombin generation, and coagulation function after hemorrhagic shock in pigs.
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Disease Models, Animal; Disease Progression; Fibrinogen; Hemodynamics; Male; Platelet Count; Random Allocation; Risk Factors; Sensitivity and Specificity; Shock, Hemorrhagic; Survival Rate; Sus scrofa; Swine; Thrombelastography; Thrombin Time; Time Factors | 2012 |
Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Biomarkers, Tumor; CA-125 Antigen; Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Prognosis; Retrospective Studies; Treatment Outcome | 2012 |
Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic function.
Topics: Animals; Antibodies, Neutralizing; Apoptosis; Blotting, Western; Caspase Inhibitors; Cell Line, Tumor; Cell Proliferation; Disease Progression; Disease-Free Survival; Down-Regulation; Fas Ligand Protein; Female; Fibrinogen; Fibrinolysin; Flow Cytometry; Gene Knockdown Techniques; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Indoleacetic Acids; Kaplan-Meier Estimate; Mice; Mice, Knockout; Neovascularization, Pathologic; Oligopeptides; Plasminogen; Plasminogen Activator Inhibitor 1; RNA, Small Interfering; Transplantation, Heterologous; Urokinase-Type Plasminogen Activator | 2012 |
Plasma fibrinogen is an accurate marker of disease activity in patients with polymyalgia rheumatica.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Sedimentation; C-Reactive Protein; Disease Progression; Female; Fibrinogen; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Predictive Value of Tests; Prospective Studies; ROC Curve | 2013 |
Mononuclear leukocyte apoptosis and inflammatory markers in patients with chronic kidney disease.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Disease Progression; fas Receptor; Female; Fibrinogen; Glomerular Filtration Rate; Humans; Inflammation; Interleukin-6; Leukocytes, Mononuclear; Male; Middle Aged; Multivariate Analysis; Proto-Oncogene Proteins c-bcl-2; Renal Insufficiency, Chronic; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2012 |
Monoclonal antibodies for immunodectection of fibrin deposits on cancer cells.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Epitopes; Extracellular Matrix; Female; Fibrin; Fibrinogen; Fibrinolysis; Gene Expression Regulation, Neoplastic; Humans; Immune System; Immunohistochemistry; Male; Neoplasm Metastasis; Neoplasms; Peptides | 2013 |
Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: a preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cohort Studies; Diabetes Mellitus, Type 2; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Peripheral Arterial Disease; Prospective Studies | 2013 |
Overexpression of fibrinogen in ApoE*3-Leiden transgenic mice does not influence the progression of diet-induced atherosclerosis.
Topics: Animals; Aortic Valve; Apolipoprotein E3; Apolipoproteins E; Arteriosclerosis; Diet, Atherogenic; Disease Progression; Fibrinogen; Humans; Mice; Mice, Transgenic; Platelet Aggregation | 2002 |
Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.
Topics: Aged; Albuminuria; Apolipoproteins B; Biomarkers; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Male; Patient Selection; Prospective Studies; Regression Analysis; Risk Factors; Smoking; Time Factors | 2003 |
Progression in lacunar stroke is related to elevated acute phase parameters.
Topics: Aged; Body Temperature; Brain Infarction; Case-Control Studies; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Leukocytes; Male; Middle Aged; Motor Activity; Neurologic Examination; Neurotransmitter Agents; Prognosis; Prospective Studies; Risk Factors; Severity of Illness Index; Stroke; Time Factors | 2004 |
Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer.
Topics: Animals; Blood Platelets; Bone Marrow; Carcinoma, Lewis Lung; Cell Adhesion; Cell Proliferation; Chemotaxis; Cyclin D2; Cyclins; Disease Progression; Endothelial Cells; Female; Fibrinogen; Hepatocyte Growth Factor; Humans; Interleukin-8; Lung Neoplasms; Matrix Metalloproteinase 14; Matrix Metalloproteinase 9; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase Kinases; Neoplasm Invasiveness; Neovascularization, Pathologic; Phosphorylation; Platelet Activation; Platelet Membrane Glycoproteins; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Umbilical Veins; Vascular Endothelial Growth Factor A | 2005 |
Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression.
Topics: alpha-2-Antiplasmin; Antithrombins; Biotinylation; Caseins; Cloning, Molecular; Disease Progression; Extracellular Matrix; Fibrinogen; Glycosylation; Humans; Hydrogen-Ion Concentration; Kallikreins; Kinetics; Mass Spectrometry; Neoplasms; Neovascularization, Pathologic; Pichia; Plasminogen; Protein Binding; Protein Structure, Tertiary; Recombinant Proteins; Serine Endopeptidases; Serpins; Substrate Specificity; Time Factors; Trypsin; Vitronectin | 2005 |
Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors.
Topics: Body Temperature; Brain; Cerebral Arteries; Cerebral Hemorrhage; Disease Progression; Encephalitis; Fibrinogen; Glasgow Coma Scale; Hematoma; Humans; Intracranial Hypertension; Leukocyte Count; Predictive Value of Tests | 2005 |
Mediation and modification of the association between hopelessness, hostility, and progression of carotid atherosclerosis.
Topics: Adult; Blood Pressure; Carotid Artery Diseases; Depression; Disease Progression; Female; Fibrinogen; Hostility; Humans; Hypothalamo-Hypophyseal System; Male; Marital Status; Middle Aged; Pituitary-Adrenal System; Psychology; Risk Factors; Tunica Intima; Ultrasonography | 2005 |
Prognostic impact of fibrinogen in carotid atherosclerosis: nonspecific indicator of inflammation or independent predictor of disease progression?
Topics: Aged; Atherosclerosis; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Prospective Studies; Risk; Risk Factors; Serum Amyloid A Protein; Time Factors; Ultrasonography | 2005 |
Characterization of a novel thrombotic middle cerebral artery occlusion model in monkeys that exhibits progressive hypoperfusion and robust cortical infarction.
Topics: Animals; Biomarkers; Cerebral Cortex; Cerebral Infarction; Cerebrovascular Circulation; Cerebrovascular Disorders; Disease Models, Animal; Disease Progression; Fibrinogen; Infarction, Middle Cerebral Artery; Intracranial Thrombosis; Macaca fascicularis; Male; Middle Cerebral Artery; Peroxidase; Photic Stimulation; Positron-Emission Tomography; Rose Bengal; Surgical Instruments | 2005 |
Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin.
Topics: Animals; Antibodies, Monoclonal; Blood Coagulation Factors; Cell Separation; Disease Progression; Endothelium, Vascular; Endotoxins; Escherichia coli; Fibrin; Fibrinogen; Flow Cytometry; Hemostasis; Hemostatics; Lipopolysaccharides; Mice; Mice, Transgenic; Promoter Regions, Genetic; Protein C; Receptor, TIE-2; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; Sepsis; Thrombin; Thrombosis; Time Factors; Transgenes | 2005 |
[Hemostasis disturbances in premature infants with respiratory distress. Influence of the severity of the distress].
Topics: Age Factors; Disease Progression; Disseminated Intravascular Coagulation; Exchange Transfusion, Whole Blood; Factor IX; Factor VII; Factor VIII; Factor X; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Infant, Newborn; Infant, Premature, Diseases; Intensive Care, Neonatal; Plasminogen; Platelet Count; Prospective Studies; Prothrombin; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Severity of Illness Index; Time Factors; Treatment Outcome | 1976 |
Adrenal axis functions in patients with familial Mediterranean fever.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Blood Sedimentation; C-Reactive Protein; Disease Progression; Familial Mediterranean Fever; Female; Fibrinogen; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System | 2006 |
Inflammatory markers in age-related maculopathy: cross-sectional analysis from the Muenster Aging and Retina Study.
Topics: Aged; Aged, 80 and over; Aging; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Disease Progression; Female; Fibrinogen; Germany; Humans; Macular Degeneration; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Retina; Risk Factors | 2005 |
Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.
Topics: Aged; Arteriosclerosis; C-Reactive Protein; Disease Progression; Female; Fibrinogen; Hemostasis; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Peripheral Vascular Diseases; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Surveys and Questionnaires; Time Factors | 2006 |
Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study.
Topics: Aged; Analysis of Variance; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; Cardiovascular System; Carotid Arteries; Carotid Artery Diseases; Chlamydophila pneumoniae; Cytomegalovirus; Disease Progression; Echocardiography, Doppler; Female; Fibrinogen; Follow-Up Studies; Helicobacter pylori; Humans; Immunoglobulin G; Infections; Inflammation; Lipids; Male; Middle Aged; Risk Factors; Sex Factors; Stroke; Time Factors; Tunica Intima; Tunica Media; Ultrasonography | 2006 |
Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B.
Topics: Animals; Disease Models, Animal; Disease Progression; Female; Fibrinogen; Hepatitis B; Hepatitis, Viral, Animal; Humans; Liver; Mice; Mice, Inbred BALB C; Murine hepatitis virus; Thromboplastin | 2005 |
Interleukin-18 levels are not associated with subclinical carotid atherosclerosis in a community population. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
Topics: Adult; Aged; Atherosclerosis; Biomarkers; C-Reactive Protein; Carotid Arteries; Carotid Artery Diseases; Cross-Sectional Studies; Disease Progression; Female; Fibrinogen; Humans; Interleukin-18; Interleukin-6; Interleukin-8; Male; Middle Aged; Population Surveillance; Prevalence; Risk Factors; Severity of Illness Index; Ultrasonography; Western Australia | 2006 |
Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Progression; Female; Fibrinogen; Glucose Tolerance Test; Humans; Incidence; Male; Middle Aged; Plasminogen Activator Inhibitor 1 | 2006 |
Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease.
Topics: Adult; Atrophy; Brain; CADASIL; Cognition Disorders; Comorbidity; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Hypercholesterolemia; Hypertension; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Risk Factors; Smoking | 2006 |
Association of C-reactive protein with the presence and extent of angiographically verified coronary artery disease.
Topics: Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Disease Progression; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Risk Factors | 2006 |
Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients.
Topics: Aged; C-Reactive Protein; Creatinine; Cross-Sectional Studies; Disease Progression; Endotoxemia; Endotoxins; Female; Fibrinogen; Glomerular Filtration Rate; Humans; Inflammation; Kidney; Kidney Failure, Chronic; Linear Models; Male; Middle Aged | 2006 |
Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Topics: Adult; Arthritis, Psoriatic; Biomarkers; C-Reactive Protein; Cells, Cultured; Disease Progression; Female; Fibrinogen; Fluorescent Antibody Technique; Humans; Immunohistochemistry; In Vitro Techniques; Inflammation; Inflammation Mediators; Interleukin-1; Interleukin-6; Male; Middle Aged; Monocytes; Psoriasis; Research Design; Serum Amyloid P-Component; Statistics as Topic; Tumor Necrosis Factor-alpha | 2006 |
Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries.
Topics: Aged; Cardiovascular Diseases; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Fibrinogen; Humans; Linear Models; Lipoprotein(a); Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Retrospective Studies; Tunica Media; Ultrasonography, Interventional | 2006 |
Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
Topics: Aged; alpha-2-Antiplasmin; Antithrombin III; C-Reactive Protein; Cohort Studies; Coronary Artery Disease; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Gene Expression Regulation; Hemostasis; Humans; Male; Middle Aged; Peptide Hydrolases; Prospective Studies; Regression Analysis; Risk Factors; von Willebrand Factor | 2006 |
Albuminuria as risk factor for initiation and progression of carotid atherosclerosis in non-diabetic persons: the Tromsø Study.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Arteriosclerosis; Biomarkers; Carotid Artery Diseases; Cohort Studies; Disease Progression; Female; Fibrinogen; Humans; Longitudinal Studies; Male; Middle Aged; Risk Factors | 2007 |
Fibrinogen metabolism in patients with spinal cord injury.
Topics: Acute Disease; Adult; Case-Control Studies; Chronic Disease; Disease Progression; Fibrin; Fibrinogen; Half-Life; Humans; Iodine Radioisotopes; Male; Middle Aged; Paralysis; Pulmonary Embolism; Risk Factors; Spinal Cord Injuries; Time Factors; Venous Thrombosis | 2006 |
Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats.
Topics: Actins; Animals; Blood Pressure; Blotting, Western; Collagen; Disease Progression; Fibrinogen; Fibrinolysin; Fibrosis; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Kidney; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microscopy, Electron; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Podocytes; Proteinuria; Pyrimidines; Rats; Rats, Inbred SHR; Rosuvastatin Calcium; Simvastatin; Stroke; Sulfonamides | 2007 |
Significance of endotoxaemia in chronic kidney disease.
Topics: C-Reactive Protein; Creatinine; Disease Progression; Endotoxemia; Endotoxins; Fibrinogen; Humans; Inflammation; Kidney; Kidney Failure, Chronic | 2007 |
Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Disease Models, Animal; Disease Progression; Fibrin; Fibrinogen; Inflammation; Mice; Mice, Transgenic; Models, Biological; Permeability; Plasminogen; Tranexamic Acid | 2007 |
Platelet activation increases with the severity of peripheral arterial disease: implications for clinical management.
Topics: Adult; Aged; Aged, 80 and over; Arachidonic Acid; Blood Platelets; Blood Pressure; Disease Progression; Female; Fibrinogen; Flow Cytometry; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intermittent Claudication; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Activation; Prognosis; Receptors, Cell Surface; Severity of Illness Index | 2007 |
Plasma fibrinogen is associated with cognitive decline and risk for dementia in patients with mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Biomarkers; Cognition Disorders; Dementia; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Psychiatric Status Rating Scales | 2008 |
Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus.
Topics: Adult; Aged; Blood Cell Count; Carcinoma, Squamous Cell; Disease Progression; Esophageal Neoplasms; Female; Fibrinogen; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Regression Analysis; Survival Rate | 2007 |
Persistent hyperfibrinogenemia in acute ischemic stroke / transient ischemic attack (TIA).
Topics: Aged; Blood Sedimentation; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Humans; Ischemic Attack, Transient; Leukocyte Count; Male; Middle Aged; Prognosis; Stroke; Time Factors; Up-Regulation | 2008 |
The relationship between the MEFV genotype, clinical features, and cytokine-inflammatory activities in patients with familial mediterranean fever.
Topics: Adult; Blood Sedimentation; C-Reactive Protein; Case-Control Studies; Cytoskeletal Proteins; Disease Progression; Familial Mediterranean Fever; Female; Fibrinogen; Follow-Up Studies; Genotype; Humans; Inflammation Mediators; Male; Probability; Pyrin; Reference Values; Risk Assessment; RNA, Messenger; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric | 2008 |
Plasma viscosity increase with progression of peripheral arterial atherosclerotic disease.
Topics: Aged; Aged, 80 and over; alpha-Macroglobulins; Arteriosclerosis; Blood Glucose; Blood Viscosity; Cholesterol; Disease Progression; Female; Fibrinogen; Humans; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged; Peripheral Vascular Diseases; Plasma; Prognosis; Risk Factors | 1996 |
Smoking as a risk factor for abdominal aortic aneurysm.
Topics: Aged; Aortic Aneurysm, Abdominal; Carboxyhemoglobin; Cotinine; Disease Progression; Female; Fibrinogen; Humans; Inhalation; Lipids; Male; Odds Ratio; Risk Factors; Single-Blind Method; Smoking; Ultrasonography | 1996 |
Haemorheology in insulin-dependent diabetes is still normal five years after onset of the disease.
Topics: Adolescent; Age Factors; Blood Viscosity; Case-Control Studies; Chi-Square Distribution; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Hematocrit; Hemorheology; Humans; Male; Prospective Studies; Sex Factors; Sweden | 1997 |
Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events.
Topics: Aged; Arteriosclerosis; Carotid Stenosis; Comorbidity; Cross-Sectional Studies; Disease Progression; Female; Femoral Artery; Fibrinogen; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Intercellular Adhesion Molecule-1; Male; Middle Aged; Organ Specificity; Random Allocation; Risk Factors; Smoking; Vascular Cell Adhesion Molecule-1 | 1998 |
Hyperfibrinogenolysis in disseminated adenocarcinoma.
Topics: Adenocarcinoma; Adult; Afibrinogenemia; alpha-2-Antiplasmin; Antifibrinolytic Agents; Brain Ischemia; Diagnosis, Differential; Disease Progression; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhagic Disorders; Humans; Lung Neoplasms; Paraneoplastic Syndromes; Tranexamic Acid | 1998 |
Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication.
Topics: Blood Viscosity; Disease Progression; Female; Fibrinogen; Hemorheology; Humans; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged; Multivariate Analysis; Peripheral Vascular Diseases; Prognosis; Prospective Studies; Regional Blood Flow; Smoking | 1998 |
Progressive expansion of hypertensive intracerebral hemorrhage by coagulopathy.
Topics: Aged; Aged, 80 and over; Antithrombin III; Blood Coagulation Disorders; Cerebral Hemorrhage; Disease Progression; Female; Fibrinogen; Fibrinopeptide A; Hematoma; Humans; Incidence; Intracranial Hypertension; Male; Middle Aged; Peptide Hydrolases; Platelet Count; Prothrombin Time | 1998 |
Fibrin deposition in squamous cell carcinomas of the larynx and hypopharynx.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease Progression; Female; Fibrin; Fibrinogen; Fluorescent Antibody Technique, Indirect; Humans; Hypopharyngeal Neoplasms; Keratins; Laryngeal Neoplasms; Macrophages; Male; Middle Aged; Neoplasm Proteins; Tenascin; Thrombophilia; Transglutaminases | 1998 |
Increased levels of soluble forms of adhesion molecules in Takayasu arteritis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiography; Biomarkers; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Histocompatibility Testing; HLA-B Antigens; HLA-B39 Antigen; HLA-B52 Antigen; Humans; Immunoenzyme Techniques; Intercellular Adhesion Molecule-1; Male; Middle Aged; Severity of Illness Index; Solubility; Takayasu Arteritis; Vascular Cell Adhesion Molecule-1 | 1998 |
[Biochemical mechanisms of thoracic fibrosis development after pneumonectomy in patients operated for progressive pulmonary tuberculosis].
Topics: Biomarkers; Disease Progression; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibronectins; Fibrosis; Follow-Up Studies; Humans; Pleura; Pneumonectomy; Thoracic Diseases; Tuberculosis, Pulmonary | 1999 |
Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter.
Topics: Aged; Angina Pectoris; Angina, Unstable; Animals; Blood Proteins; Body Temperature; C-Reactive Protein; Cardiac Catheterization; Coronary Artery Disease; Coronary Vessels; Disease Progression; Energy Metabolism; Female; Fibrinogen; Humans; Lipids; Macrophage Activation; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Rupture, Spontaneous; Swine; Thermography | 1999 |
MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study.
Topics: Aged; Austria; Blood Pressure; Brain; Cerebrovascular Disorders; Cognition; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Magnetic Resonance Imaging; Male; Middle Aged; Odds Ratio; Risk Factors; Time Factors | 1999 |
Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study.
Topics: Aged; Antifibrinolytic Agents; Antigens; Biomarkers; Blood Coagulation Factors; Cohort Studies; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Ischemia; Male; Middle Aged; Peripheral Vascular Diseases; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Surveys and Questionnaires; Tissue Plasminogen Activator; Urban Population; von Willebrand Factor | 2000 |
Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
Topics: Adult; Aged; Antineoplastic Agents; Blood Cell Count; Blood Viscosity; Breast Neoplasms; Carcinoma; Cell Hypoxia; Cohort Studies; Disease Progression; Erythrocyte Aggregation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Genital Neoplasms, Female; Germany; Hematocrit; Hemorheology; Humans; Life Tables; Microcirculation; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Ovarian Neoplasms; Prospective Studies; Risk Factors; Survival Analysis; Thrombophilia; Uterine Cervical Neoplasms; Uterine Neoplasms; Venous Thrombosis | 2000 |
Plasma viscosity and fibrinogen in relation to haemodynamic findings in chronic congestive heart failure.
Topics: Adult; Aged; Biomarkers; Blood Viscosity; Chronic Disease; Disease Progression; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Prognosis; Radionuclide Ventriculography; Stroke Volume | 1999 |
Identification of genes associated with the progression of adult T cell leukemia (ATL).
Topics: Amino Acid Sequence; Animals; Base Sequence; Cattle; Cloning, Molecular; Disease Progression; Down-Regulation; Electron Transport Complex I; Fibrinogen; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Prolymphocytic, T-Cell; Leukocytes, Mononuclear; Membrane Transport Proteins; Molecular Sequence Data; Myelin and Lymphocyte-Associated Proteolipid Proteins; Myelin Proteins; NADH, NADPH Oxidoreductases; Oligonucleotide Array Sequence Analysis; Proteolipids; Receptors, CCR7; Receptors, Cell Surface; Receptors, Chemokine; RNA, Messenger; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Tumor Cells, Cultured; Up-Regulation | 2000 |
Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery.
Topics: Animals; Aorta, Thoracic; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Carotid Artery Diseases; Carotid Artery Injuries; Carotid Artery, Common; Carotid Stenosis; Disease Progression; Fibrin; Fibrinogen; Hemorheology; Male; Mice; Mice, Knockout; Photochemistry; Plasminogen; Plasminogen Activator Inhibitor 1 | 2000 |
Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model.
Topics: Animals; Blood-Brain Barrier; Brain; Chronic Disease; Disease Models, Animal; Disease Progression; Endothelium, Vascular; Fibrinogen; Glucose Transporter Type 1; Host-Parasite Interactions; Intercellular Adhesion Molecule-1; Male; Membrane Proteins; Microcirculation; Monosaccharide Transport Proteins; Occludin; Phosphoproteins; Rats; Tight Junctions; Trypanosoma brucei brucei; Trypanosomiasis, African; Vascular Cell Adhesion Molecule-1; Zonula Occludens-1 Protein | 2001 |
[Biochemical aspects of assessing reactivity of pulmonary tuberculosis patients].
Topics: alpha 1-Antitrypsin; C-Reactive Protein; Disease Progression; Fibrinogen; Fibronectins; Haptoglobins; Humans; Tuberculosis, Pulmonary | 2001 |
Polymyalgia rheumatica (PMR): clinical, laboratory, and immunofluorescence studies in 13 patients.
Topics: Aged; Aged, 80 and over; Disease Progression; Female; Fibrinogen; Fluorescent Antibody Technique; Humans; Immunoglobulin A; Immunoglobulin G; Inflammation; Male; Middle Aged; Muscle, Skeletal; Polymyalgia Rheumatica; Retrospective Studies | 2002 |